https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-and-the-effect-of-bms-241027-on-cerebrospinal-fluid-biomarkers-in-subjects-wit-65002https://curecurrent.com/trials/proof-of-concept-study-of-cognitive-improvement-in-patients-with-alzheimer-s-disease-65003https://curecurrent.com/trials/a-randomized-clinical-trial-of-vitamin-e-and-memantine-in-alzheimer-s-disease-65004https://curecurrent.com/trials/physical-activity-training-program-for-patients-with-alzheimer-s-dementia-65005https://curecurrent.com/trials/effects-of-exercise-on-cognitive-performance-of-patients-with-alzheimer-type-dementia-pilot-study-65006https://curecurrent.com/trials/hippocampus-study-comparative-effect-of-donepezil-10mg-d-and-placebo-on-clinical-and-radiological-markers-65007https://curecurrent.com/trials/hormone-and-information-processing-study-65008https://curecurrent.com/trials/safety-study-of-trx0237-in-patients-already-taking-medications-for-mild-and-moderate-alzheimer-s-disease-65009https://curecurrent.com/trials/comparison-of-23-mg-donepezil-sustained-release-sr-to-10-mg-donepezil-immediate-release-ir-in-patients-with-moderate-to-65010https://curecurrent.com/trials/experimental-study-to-validate-the-therapeutic-game-conem-beta-65011https://curecurrent.com/trials/experimental-study-of-the-impact-of-a-group-therapy-psychological-intervention-for-caregivers-of-alzheimer-s-disease-pat-65012https://curecurrent.com/trials/alzheimer-and-sleep-65013https://curecurrent.com/trials/azd3293-thorough-qt-study-in-healthy-male-volunteers-65014https://curecurrent.com/trials/a-phase-i-clinical-dose-escalation-study-of-the-safety-tolerability-and-pharmacokinetics-of-donepezil-patch-in-healthy-m-65015https://curecurrent.com/trials/delta-thc-in-dementia-65016https://curecurrent.com/trials/citalopram-for-agitation-in-alzheimer-s-disease-65017https://curecurrent.com/trials/florbetaben-bay94-9172-pet-positron-emission-tomography-imaging-in-mci-mild-cognitive-impairment-patients-65018https://curecurrent.com/trials/long-term-use-of-galantamine-versus-nootropics-memory-enhancing-drugs-in-patients-with-alzheimer-s-dementia-under-condit-65019https://curecurrent.com/trials/a-phase-i-open-label-single-center-study-to-assess-the-absorption-metabolism-and-excretion-of-14c-azd3293-65020https://curecurrent.com/trials/progression-delaying-effect-of-escitalopram-in-alzheimer-s-disease-65021https://curecurrent.com/trials/safety-of-switching-from-donepezil-to-rivastigmine-patch-in-patients-with-probable-alzheimer-s-disease-65022https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-blood-levels-of-pf-03654746-in-subjects-with-mild-to-moderate-alzheimer-65023https://curecurrent.com/trials/research-involving-subjects-with-parkinson-s-disease-alzheimer-disease-and-healthy-controls-65024https://curecurrent.com/trials/phase-1-and-phase-2-clinical-trials-of-snubh-nm-333-18f-65025https://curecurrent.com/trials/an-observational-study-of-the-safety-and-effectiveness-of-galantamine-in-the-treatment-of-patients-with-alzheimer-s-dise-65026https://curecurrent.com/trials/effects-of-sleep-deprivation-on-cerebrospinal-fluid-csf-amyloid-beta-a-dynamics-65027https://curecurrent.com/trials/cilostazol-augmentation-study-in-dementia-65028https://curecurrent.com/trials/amyloid-imaging-and-safety-study-of-subcutaneous-bapineuzumab-in-subjects-with-mild-to-moderate-alzheimer-s-disease-65029https://curecurrent.com/trials/evaluation-of-123-i-iodobenzovesamicol-ibvm-and-spect-imaging-of-healthy-subjects-and-patients-with-alzheimer-disease-65030https://curecurrent.com/trials/study-of-octagam-intravenous-immunoglobulin-ivig-10-on-the-treatment-of-mild-to-moderate-alzheimer-s-disease-65031https://curecurrent.com/trials/the-circadian-study-evaluation-of-modulating-effect-of-galantamine-on-circadian-rhythm-in-patients-with-mild-to-moderate-65032https://curecurrent.com/trials/safety-and-cognitive-function-study-of-evp-6124-in-patients-with-mild-to-moderate-alzheimer-s-disease-65033https://curecurrent.com/trials/safety-and-tolerability-of-etanercept-in-alzheimer-s-disease-65034https://curecurrent.com/trials/cerebrospinal-fluid-csf-biomarkers-alzheimer-s-disease-ad-and-non-ad-dementias-65035https://curecurrent.com/trials/effects-of-exercise-training-in-patients-with-mild-cognitive-impairment-65036https://curecurrent.com/trials/effect-of-neuroad-on-alzheimer-patients-65037https://curecurrent.com/trials/effects-of-exercise-training-in-patients-with-mild-cognitive-impairment-and-early-alzheimer-s-disease-65038https://curecurrent.com/trials/an-efficacy-and-safety-study-of-galantamine-for-the-treatment-of-patients-with-alzheimer-s-disease-65039https://curecurrent.com/trials/prism-registry-pseudobulbar-affect-registry-series-65040https://curecurrent.com/trials/a-study-to-examine-the-distribution-of-pf-05212377-in-the-brain-of-healthy-volunteer-subjects-using-positron-emission-to-65041https://curecurrent.com/trials/yogic-breathing-changes-salivary-components-65042https://curecurrent.com/trials/prospective-memory-imaging-65043https://curecurrent.com/trials/imaging-of-new-learning-in-severe-alzheimer-s-disease-patients-65044https://curecurrent.com/trials/a-two-part-multiple-dose-study-to-assess-the-safety-and-effects-of-azd3293-in-healthy-elderly-and-alzheimer-s-patients-65045https://curecurrent.com/trials/evaluation-of-efficacy-and-safety-of-galantamine-in-patients-with-dementia-of-alzheimer-s-type-who-failed-to-benefit-fro-65046https://curecurrent.com/trials/inappropriate-medications-associated-with-anticholinesterase-and-or-memantine-treatment-in-the-elderly-65047https://curecurrent.com/trials/a-study-to-measure-csf-proteins-in-elderly-healthy-volunteers-and-volunteers-with-mild-cognitive-impairment-or-alzheimer-65048https://curecurrent.com/trials/efficacy-of-pulsatile-iv-insulin-on-cognition-and-amyloid-burden-in-patients-with-alzheimer-s-disease-65049https://curecurrent.com/trials/observational-study-of-donepezil-in-routine-clinical-practice-65050https://curecurrent.com/trials/treating-behavioral-disturbances-in-individuals-with-dementia-65051https://curecurrent.com/trials/evaluation-of-a-handheld-event-related-potential-erp-quantitative-electroencephalography-qeeg-system-cognision-as-a-usef-65052https://curecurrent.com/trials/assess-123-i-impy-and-spect-imaging-as-a-tool-to-detect-amyloid-in-the-brain-65053https://curecurrent.com/trials/treatment-for-early-memory-loss-65054https://curecurrent.com/trials/effect-of-exercises-training-in-patients-with-mild-cognitive-impairment-and-early-alzheimer-s-disease-65055https://curecurrent.com/trials/the-study-of-microrna-107-mirna-107-and-beta-amyloid-precursor-protein-cleaving-enzyme-1-bace1-messenger-ribonucleic-aci-65056https://curecurrent.com/trials/genes-exercise-memory-and-neurodegeneration-65057https://curecurrent.com/trials/a-pilot-trial-of-interferon-beta-1a-in-alzheimer-s-disease-65058https://curecurrent.com/trials/efficacy-and-safety-of-rivastigmine-transdermal-patch-in-patients-with-mild-to-moderate-alzheimer-s-disease-65059https://curecurrent.com/trials/evaluation-of-safety-tolerability-of-multiple-dose-regimens-of-chf-5074-and-exploration-of-effects-on-potential-markers-65060https://curecurrent.com/trials/evaluation-of-safety-tolerability-of-multiple-dose-regimens-of-chf-5074-and-exploration-of-effects-on-potential-markers-65061https://curecurrent.com/trials/measurement-of-retinal-nerve-fiber-layer-thickness-a-biomarker-for-the-early-detection-of-alzheimer-s-disease-65062https://curecurrent.com/trials/magnetic-resonance-spectroscopy-study-of-memantine-in-alzheimer-s-disease-65063https://curecurrent.com/trials/effect-of-repetitive-transcranial-magnetic-stimulation-on-language-in-alzheimer-s-disease-65064https://curecurrent.com/trials/effectiveness-of-an-electronic-training-program-for-orienting-and-interpreting-18f-flutemetamol-positron-emission-tomogr-65065https://curecurrent.com/trials/nutritional-programme-for-dementia-elderly-patient-65066https://curecurrent.com/trials/delta-thc-in-behavioral-disturbances-in-dementia-65067https://curecurrent.com/trials/the-detection-of-early-dementia-with-the-digital-game-memory-65068https://curecurrent.com/trials/new-proteins-in-body-fluids-as-potential-biomarker-for-alzheimer-s-disease-a-pilot-study-65069https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-jnj-54861911-in-healthy-elderly-65070https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-of-evp-0962-and-effects-of-evp-0962-on-cerebral-spinal-fluid-amyloid-concentrations-65071https://curecurrent.com/trials/efficacy-of-early-stage-alzheimer-s-support-groups-65072https://curecurrent.com/trials/effects-of-transcranial-direct-current-stimulation-on-the-apathy-of-alzheimer-s-disease-65073https://curecurrent.com/trials/a-long-term-safety-and-tolerability-study-of-bapineuzumab-in-alzheimer-disease-patients-65074https://curecurrent.com/trials/blood-brain-barrier-leakage-in-dementia-a-dynamic-contrast-enhanced-mri-study-65075https://curecurrent.com/trials/a-long-term-safety-and-tolerability-study-in-subjects-with-mild-to-moderate-alzheimer-s-disease-65076https://curecurrent.com/trials/smart-somatotrophics-memory-and-aging-research-trial-65077https://curecurrent.com/trials/cognitive-behavioural-therapy-for-persons-with-mci-or-mild-dementia-65078https://curecurrent.com/trials/positron-emission-tomography-imaging-of-brain-amyloid-in-normal-pressure-hydrocephalus-65079https://curecurrent.com/trials/clinical-and-immunological-activity-safety-and-tolerability-of-different-doses-formulations-of-affitope-ad02-in-early-al-65080https://curecurrent.com/trials/observational-follow-up-extension-study-of-aff002-and-aff004a-in-patients-with-alzheimer-s-disease-65081https://curecurrent.com/trials/vi-1121-for-the-treatment-alzheimer-s-disease-65082https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-abt-354-in-subjects-with-mild-to-moderate-alzheimer-s-disease-on-stable-dose-65083https://curecurrent.com/trials/blood-brain-barrier-permeability-in-alzheimer-s-disease-65084https://curecurrent.com/trials/usability-study-of-spaced-retrieval-exercise-using-mobile-devices-for-alzheimer-s-disease-rehabilitation-65085https://curecurrent.com/trials/efficacy-and-safety-of-memantine-in-moderate-to-severe-alzheimer-s-disease-65086https://curecurrent.com/trials/positron-emission-tomography-pet-imaging-of-brain-amyloid-compared-to-post-mortem-levels-65087https://curecurrent.com/trials/impact-of-a-memory-group-for-older-adults-reporting-memory-difficulties-65088https://curecurrent.com/trials/aripiprazole-in-the-treatment-of-patients-with-psychosis-associated-with-dementia-of-alzheimer-s-type-65089https://curecurrent.com/trials/multiple-nutritional-deficiencies-causing-dementia-of-the-alzheimer-type-65090https://curecurrent.com/trials/a-confirmatory-trial-of-sk-pc-b70m-in-mild-to-moderate-alzheimer-s-disease-65091https://curecurrent.com/trials/construction-lbd-constructional-apraxia-in-alzheimer-s-disease-ad-and-lewy-body-s-dementia-lbd-65092https://curecurrent.com/trials/aab-001-bapineuzumab-open-label-long-term-extension-study-in-patients-with-mild-to-moderate-alzheimer-s-disease-65093https://curecurrent.com/trials/bapineuzumab-in-patients-with-mild-to-moderate-alzheimer-s-disease-apoe4-non-carrier-65094https://curecurrent.com/trials/bapineuzumab-in-patients-with-mild-to-moderate-alzheimer-s-disease-apoe4-carrier-65095https://curecurrent.com/trials/correlation-between-regional-brain-volume-and-response-to-donepezil-treatment-in-ad-patients-65096https://curecurrent.com/trials/study-evaluating-bapineuzumab-in-alzheimer-disease-subjects-65097https://curecurrent.com/trials/a-comparison-of-two-standard-therapies-in-the-management-of-dementia-with-agitation-65098https://curecurrent.com/trials/study-of-aripiprazole-in-the-treatment-of-patients-with-psychosis-associated-with-dementia-of-the-alzheimer-s-type-65099https://curecurrent.com/trials/intramuscular-aripiprazole-in-acutely-agitated-patients-diagnosed-with-dementia-65100https://curecurrent.com/trials/evaluation-of-18f-pbr111-and-pet-as-a-marker-of-inflammation-in-subjects-with-neurological-conditions-65101https://curecurrent.com/trials/study-of-aripiprazole-in-the-treatment-of-patients-with-psychosis-associated-with-dementia-of-the-alzheimer-s-type-65102https://curecurrent.com/trials/evaluation-of-18f-fmh3-and-pet-as-a-marker-of-histamine-3-receptor-activity-in-subjects-with-ad-compared-w-hc-65103https://curecurrent.com/trials/follow-up-study-to-evaluate-long-term-safety-and-tolerability-of-immunization-with-ad03-applied-during-aff005a-65104https://curecurrent.com/trials/efficacy-and-safety-of-t-817ma-in-patients-with-mild-to-moderate-alzheimer-s-disease-65105https://curecurrent.com/trials/an-evaluation-of-three-doses-of-ns-2330-in-patients-with-mild-to-moderate-dementia-of-the-alzheimer-s-type-65106https://curecurrent.com/trials/internet-app-to-self-manage-occasional-low-back-pain-65107https://curecurrent.com/trials/alzheimer-s-family-research-65108https://curecurrent.com/trials/a-monocenter-cross-sectional-study-to-compare-different-type-of-cognitive-impairment-in-multiple-sclerosis-patients-and-65109https://curecurrent.com/trials/a-phase-ii-trial-of-florbetapir-18f-positron-emission-tomography-pet-imaging-in-japan-of-healthy-volunteers-patients-wit-65110https://curecurrent.com/trials/a-study-of-galantamine-used-to-treat-patients-with-mild-to-moderate-alzheimer-s-disease-65111https://curecurrent.com/trials/a-study-of-florbetapir-18f-in-japanese-healthy-volunteers-65112https://curecurrent.com/trials/effects-of-exercise-and-cognitive-training-on-cognitive-function-in-older-adults-65113https://curecurrent.com/trials/zydena-on-cognitive-function-of-alzheimer-s-disease-patients-65114https://curecurrent.com/trials/acute-effects-of-donepezil-on-brain-perfusion-and-memory-in-subjects-with-cognitive-impairment-and-mild-alzheimer-s-dise-65115https://curecurrent.com/trials/multiple-ascending-dose-study-of-tc-5619-in-healthy-elderly-subjects-and-subjects-with-alzheimer-s-disease-65116https://curecurrent.com/trials/evaluation-of-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-e2609-in-healthy-subjects-and-an-elderly-65117https://curecurrent.com/trials/effects-of-rivastigmine-patch-on-activities-of-daily-living-and-cognition-in-patients-with-severe-dementia-of-the-alzhei-65118https://curecurrent.com/trials/the-efficacy-of-a-combination-regimen-in-patients-with-mild-to-moderate-probable-alzheimer-s-disease-65119https://curecurrent.com/trials/a-study-to-show-that-the-change-of-attention-measure-is-correlated-with-the-changes-of-caregiver-s-burden-after-treatmen-65120https://curecurrent.com/trials/evaluation-of-the-neuroinflammation-pattern-of-bay85-8102-f-18-dpa-714-in-probable-alzheimers-disease-patients-versus-he-65121https://curecurrent.com/trials/a-phase-0-open-label-multi-center-exploratory-and-safety-study-of-f-18-t807-65122https://curecurrent.com/trials/a-phase-0-open-label-multi-center-exploratory-and-safety-study-of-f-18-t808-65123https://curecurrent.com/trials/multistimulation-group-therapy-for-alzheimer-s-disease-65124https://curecurrent.com/trials/positron-emission-tomography-pet-amyloid-imaging-of-the-brain-in-healthy-young-adult-subjects-65125https://curecurrent.com/trials/safety-and-efficacy-study-of-ac-3933-in-adults-with-mild-to-moderate-alzheimer-s-disease-65126https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-for-apathy-treatment-in-alzheimer-s-disease-65127https://curecurrent.com/trials/alpha-synuclein-in-cerebrospinal-fluid-to-differentiate-alzheimer-s-disease-from-lewy-body-disease-65128https://curecurrent.com/trials/biomarker-study-to-diagnose-alzheimer-s-disease-65129https://curecurrent.com/trials/amyloid-accumulation-after-mild-traumatic-brain-injury-65130https://curecurrent.com/trials/deep-brain-stimulation-dbs-of-the-nucleus-basalis-meynert-nbm-to-treat-cognitive-deficits-in-light-to-moderate-alzheimer-65131https://curecurrent.com/trials/nmda-enhancing-agent-for-treatment-of-mild-cognitive-impairment-and-mild-alzheimer-s-disease-65132https://curecurrent.com/trials/mirtazapine-for-sleep-disorders-in-alzheimer-s-disease-65133https://curecurrent.com/trials/study-of-the-effects-of-cerefolin-nac-on-inflammation-blood-markers-in-older-individuals-with-memory-complaints-65134https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-sequential-ascending-single-dose-study-to-evaluate-the-safety-tolerability-65135https://curecurrent.com/trials/an-study-to-determine-the-bioavailability-of-e2609-tablets-compared-to-capsules-and-the-effect-of-food-on-absorption-65136https://curecurrent.com/trials/computer-based-training-for-mild-alzheimer-s-disease-65137https://curecurrent.com/trials/nac-003-p-l-u-s-program-progress-through-learning-understanding-support-65138https://curecurrent.com/trials/antipsychotic-discontinuation-in-alzheimer-s-disease-65139https://curecurrent.com/trials/identifying-potential-effects-of-liraglutide-on-degenerative-changes-65140https://curecurrent.com/trials/a-survey-study-of-the-treatment-and-outcome-management-in-patients-diagnosed-with-alzheimer-s-disease-65141https://curecurrent.com/trials/functional-brain-imaging-of-medication-treatment-response-in-mild-alzheimer-s-disease-patients-65142https://curecurrent.com/trials/pregnenolone-sulfate-an-early-marker-of-the-memory-loss-in-alzheimer-s-disease-65143https://curecurrent.com/trials/a-study-to-evaluate-the-abuse-potential-of-single-oral-doses-of-dimebon-latrepirdine-in-healthy-recreational-polydrug-us-65144https://curecurrent.com/trials/safety-and-tolerability-study-in-patients-with-mild-to-moderate-alzheimer-s-disease-ad-65145https://curecurrent.com/trials/observational-study-of-cognitive-outcomes-for-subjects-who-have-had-prior-pet-amyloid-imaging-with-florbetapir-f-18-18f-65146https://curecurrent.com/trials/tms-stimulation-and-cognitive-training-in-alzheimer-patients-65147https://curecurrent.com/trials/ginkgo-biloba-prevention-trial-in-older-individuals-65148https://curecurrent.com/trials/multi-modal-neuroimaging-in-alzheimer-s-disease-65149https://curecurrent.com/trials/icare-stress-management-e-training-for-dementia-family-caregivers-65150https://curecurrent.com/trials/memantine-and-validation-of-a-new-alzheimer-s-disease-scale-65151https://curecurrent.com/trials/the-prevalence-of-vitamin-d-deficiency-in-patients-with-alzheimer-s-disease-65152https://curecurrent.com/trials/antidepressant-medication-plus-donepezil-for-treating-late-life-depression-65153https://curecurrent.com/trials/efficacy-and-safety-of-lornoxicam-in-patients-with-mild-to-moderate-probable-alzheimer-s-disease-65154https://curecurrent.com/trials/relationship-between-vestibular-function-and-topographic-memory-65155https://curecurrent.com/trials/efficacy-and-safety-study-for-subjects-with-mild-to-moderate-alzheimer-s-disease-65156https://curecurrent.com/trials/study-comparing-3-dosage-levels-of-sam-531-in-outpatients-with-mild-to-moderate-alzheimer-disease-65157https://curecurrent.com/trials/to-compare-positron-emission-tomography-pet-measurements-of-fibrillar-amyloid-burden-65158https://curecurrent.com/trials/efficacy-and-safety-study-of-abt-384-in-subjects-with-mild-to-moderate-alzheimer-s-disease-65159https://curecurrent.com/trials/use-of-different-treatment-care-methods-in-patients-with-dementia-associated-with-alzheimer-s-disease-65160https://curecurrent.com/trials/memantine-on-aggression-and-agitation-of-alzheimer-s-disease-ad-65161https://curecurrent.com/trials/evaluation-of-the-diagnostic-potential-of-bay1006578-in-probable-alzheimers-disease-patients-versus-healthy-volunteers-a-65162https://curecurrent.com/trials/effects-of-rosiglitazone-extended-release-tablets-on-cerebral-glucose-utilisation-and-cognition-alzheimers-disease-65163https://curecurrent.com/trials/efficacy-and-safety-of-filgrastim-in-alzheimer-s-disease-65164https://curecurrent.com/trials/the-efficacy-of-galantamine-treatment-on-attention-in-patients-with-alzheimer-s-disease-65165https://curecurrent.com/trials/ecological-assessment-of-apathy-in-alzheimer-s-disease-and-in-control-subjects-video-recognition-and-actigraphy-65166https://curecurrent.com/trials/study-of-nasal-insulin-to-fight-forgetfulness-long-acting-insulin-detemir-21-days-65167https://curecurrent.com/trials/therapeutic-effect-of-direct-current-stimulation-on-cognitive-function-of-mild-to-moderate-alzheimer-patients-65168https://curecurrent.com/trials/safety-and-efficacy-study-of-fx-1006a-in-patients-with-familial-amyloidosis-65169https://curecurrent.com/trials/an-extension-of-study-fx-005-evaluating-long-term-safety-and-clinical-outcomes-of-fx-1006a-in-patients-with-transthyreti-65170https://curecurrent.com/trials/effect-of-ly2062430-on-the-progression-of-alzheimer-s-disease-65171https://curecurrent.com/trials/an-open-positron-emission-tomography-study-to-assess-the-effects-of-varying-mass-of-azd4694-on-radioligand-binding-param-65172https://curecurrent.com/trials/evaluating-the-impact-of-donepezil-hydrochloride-aricept-on-behavioral-and-psychological-symptoms-in-patients-with-sever-65173https://curecurrent.com/trials/ac-1204-long-term-efficacy-response-trial-alert-protocol-65174https://curecurrent.com/trials/randomized-trial-of-a-nutritional-supplement-in-alzheimer-s-disease-65175https://curecurrent.com/trials/an-extension-to-the-b1451027-protocol-to-evaluate-the-long-term-safety-and-tolerability-of-dimebon-in-patients-with-alzh-65176https://curecurrent.com/trials/the-effect-of-jnj-39393406-on-event-related-potentials-in-stable-schizophrenic-patients-65177https://curecurrent.com/trials/a-study-to-evaluate-sleep-quality-in-patients-with-mild-to-moderate-alzheimer-s-disease-65178https://curecurrent.com/trials/trazodone-for-sleep-disorders-in-alzheimer-s-disease-65179https://curecurrent.com/trials/effects-of-delivery-mode-of-cognition-intervention-in-early-alzheimer-s-disease-65180https://curecurrent.com/trials/an-extension-to-the-b1451006-protocol-to-evaluate-the-safety-and-efficacy-of-dimebon-in-subjects-with-moderate-to-severe-65181https://curecurrent.com/trials/a-phase-3-efficacy-study-of-dimebon-in-patients-with-moderate-to-severe-alzheimer-s-disease-65182https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-tideglusib-to-treat-mild-to-moderate-alzheimer-s-disease-patients-65183https://curecurrent.com/trials/the-long-term-safety-and-efficacy-follow-up-study-of-subjects-who-completed-the-phase-i-clinical-trial-of-neurostem-ad-65184https://curecurrent.com/trials/efficacy-and-tolerability-of-mlc601-in-patients-with-mild-to-moderate-alzheimer-disease-who-were-unable-to-tolerate-or-f-65185https://curecurrent.com/trials/randomized-trial-of-exercise-and-social-interaction-in-a-community-based-sample-of-non-demented-chinese-elders-65186https://curecurrent.com/trials/clinical-research-center-for-dementia-of-south-korea-credos-or-crcd-65187https://curecurrent.com/trials/phase-ii-study-for-amyloid-binding-imaging-study-of-18f-av-45-in-patients-with-mild-cognitive-impairment-alzheimer-s-dis-65188https://curecurrent.com/trials/effect-of-pf-04360365-on-abeta-in-patients-with-alzheimer-s-disease-and-healthy-volunteers-65189https://curecurrent.com/trials/a-biomarker-study-of-solanezumab-in-patients-with-and-without-alzheimer-s-65190https://curecurrent.com/trials/effect-of-ly2062430-on-the-progression-of-alzheimer-s-disease-65191https://curecurrent.com/trials/comparative-efficacy-safety-and-tolerability-of-rivastigmine-10-and-15-cm-2-patch-in-patients-with-alzheimer-s-disease-a-65192https://curecurrent.com/trials/sniff-120-study-of-nasal-insulin-to-fight-forgetfulness-120-days-65193https://curecurrent.com/trials/non-expensive-and-widely-available-tests-as-diagnostic-tools-in-dementia-and-their-ability-to-predict-disease-progressio-65194https://curecurrent.com/trials/a-clinical-study-evaluating-the-effects-of-memantine-on-brain-atrophy-in-patients-with-alzheimer-s-disease-65195https://curecurrent.com/trials/safety-study-of-hpp854-in-subjects-with-mild-cognitive-impairment-or-a-diagnosis-of-mild-alzheimer-s-disease-65196https://curecurrent.com/trials/safety-and-tolerability-of-memantine-in-moderate-to-severe-alzheimer-s-disease-65197https://curecurrent.com/trials/exploratory-and-safety-study-of-f-18-w372-65198https://curecurrent.com/trials/a-trial-of-18f-av-133-and-18f-av-45-positron-emission-tomography-pet-65199https://curecurrent.com/trials/video-based-coping-skills-training-for-caregivers-65200https://curecurrent.com/trials/thalidomide-for-patients-with-mild-to-moderate-alzheimer-s-disease-65201https://curecurrent.com/trials/alzheimer-s-in-long-term-care-treatment-for-agitation-65202https://curecurrent.com/trials/ability-of-18f-av-45-pet-scan-to-distinguish-alzheimer-s-disease-subjects-from-cognitively-normal-individuals-65203https://curecurrent.com/trials/performance-of-aclarusdx-a-blood-based-transcriptomic-test-for-ad-in-us-patients-newly-referred-to-a-memory-center-65204https://curecurrent.com/trials/chronic-electrical-stimulation-of-hypothalamus-fornix-in-alzheimer-s-disease-65205https://curecurrent.com/trials/ubiquitous-spaced-retrieval-based-memory-advancement-and-rehabilitation-training-65206https://curecurrent.com/trials/evaluation-of-a-diet-in-patients-with-senile-dementia-65207https://curecurrent.com/trials/establish-taiwan-alzheimer-s-disease-neuroimaging-initiative-a-three-year-pilot-study-65208https://curecurrent.com/trials/a-study-of-two-doses-of-18f-av-45-in-alzheimer-s-disease-and-healthy-volunteers-65209https://curecurrent.com/trials/the-clinical-study-of-pitavastatin-treatment-for-group-of-mild-to-moderate-alzheimer-s-disease-65210https://curecurrent.com/trials/behavioral-sleep-intervention-in-adult-family-homes-65211https://curecurrent.com/trials/effects-of-ono-2506po-in-patients-with-alzheimer-s-disease-65212https://curecurrent.com/trials/pet-imaging-of-brain-amyloid-in-normal-pressure-hydrocephalus-65213https://curecurrent.com/trials/evaluation-of-physician-training-methods-to-read-florbetapir-pet-scans-65214https://curecurrent.com/trials/a-randomized-study-to-evaluate-fk962-in-subjects-with-mild-to-moderate-alzheimer-s-disease-65215https://curecurrent.com/trials/evaluation-of-web-based-training-to-educate-physicians-in-the-methods-of-interpreting-florbetapir-pet-scans-65216https://curecurrent.com/trials/preliminary-efficacy-and-safety-study-of-st101-plus-aricept-in-alzheimer-s-disease-65217https://curecurrent.com/trials/preliminary-efficacy-and-safety-study-of-st101-in-alzheimer-s-disease-65218https://curecurrent.com/trials/evaluation-of-pet-scan-timing-relative-to-av-45-injection-time-65219https://curecurrent.com/trials/mindfulness-based-stress-reduction-for-adults-with-mild-cognitive-impairment-65220https://curecurrent.com/trials/phase-iii-study-of-the-correlation-between-florbetapir-f18-pet-imaging-and-amyloid-pathology-in-the-brain-65221https://curecurrent.com/trials/a-preliminary-study-of-18f-av-45-in-alzheimer-s-disease-and-healthy-elderly-volunteers-65222https://curecurrent.com/trials/a-study-of-18f-av-45-in-healthy-volunteers-65223https://curecurrent.com/trials/a-study-of-18f-av-45-in-alzheimer-s-disease-ad-and-healthy-volunteers-65224https://curecurrent.com/trials/a-phase-ii-trial-of-18f-av-45-positron-emission-tomography-pet-imaging-in-healthy-volunteers-patients-with-mild-cognitiv-65225https://curecurrent.com/trials/enhancing-quality-of-life-for-nursing-home-residents-65226https://curecurrent.com/trials/safety-study-of-passive-immunization-for-patients-with-mild-to-moderate-alzheimer-s-disease-65227https://curecurrent.com/trials/multicenter-vitamin-e-trial-in-aging-persons-with-down-syndrome-65228https://curecurrent.com/trials/vitamin-e-in-aging-persons-with-down-syndrome-65229https://curecurrent.com/trials/a-phase-1-study-of-the-safety-tolerability-and-pharmacokinetics-of-abt-126-in-subjects-with-alzheimer-s-disease-65230https://curecurrent.com/trials/evaluation-of-alteration-by-magnetic-resonance-imaging-mri-in-dementia-among-elderly-subjects-65231https://curecurrent.com/trials/the-safety-and-the-efficacy-evaluation-of-neurostem-ad-in-patients-with-alzheimer-s-disease-65232https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-study-of-evp-6124-in-patients-with-alzheimer-s-disease-65233https://curecurrent.com/trials/clinical-effectiveness-of-10-cm-2-rivastigmine-patch-in-patients-with-alzheimer-s-disease-65234https://curecurrent.com/trials/an-observational-study-for-analysis-of-mortality-in-participants-who-participated-in-previous-3-studies-of-galantamine-65235https://curecurrent.com/trials/study-of-octohydroaminoacridine-succinate-tablets-in-patients-with-alzheimer-s-disease-65236https://curecurrent.com/trials/assessment-of-safety-tolerability-and-blood-concentrations-of-single-doses-of-azd3839-in-healthy-volunteers-65237https://curecurrent.com/trials/memory-disorders-registry-65238https://curecurrent.com/trials/comparison-of-3-learning-methods-to-improve-independent-activities-of-daily-living-iadls-in-alzheimer-disease-65239https://curecurrent.com/trials/non-pharmacological-management-of-behavioural-symptoms-in-nursing-home-65240https://curecurrent.com/trials/truncated-and-extended-forms-of-amyloid-beta-peptides-in-alzheimer-s-disease-genesis-toxicity-and-identification-as-biol-65241https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-galantamine-hydrobromide-in-patients-with-alzheimer-s-disease-65242https://curecurrent.com/trials/effects-of-exercise-and-rivastigmine-on-quality-of-life-of-alzheimer-s-disease-patients-65243https://curecurrent.com/trials/aab-001-in-patients-with-mild-to-moderate-alzheimer-s-disease-65244https://curecurrent.com/trials/predictive-value-of-cognitive-tests-performed-for-the-diagnosis-of-alzheimer-s-disease-and-related-disorders-65245https://curecurrent.com/trials/self-care-talk-study-promoting-alzheimer-s-disease-ad-spousal-caregiver-health-65246https://curecurrent.com/trials/the-safety-and-efficacy-of-neramexane-in-patients-with-moderate-to-severe-alzheimer-s-disease-65247https://curecurrent.com/trials/an-evaluation-of-the-safety-and-efficacy-of-memantine-in-agitated-patients-with-moderate-to-severe-alzheimer-s-disease-65248https://curecurrent.com/trials/escitalopram-treatment-of-patients-with-agitated-dementia-65249https://curecurrent.com/trials/evaluation-of-18f-feppa-and-pet-imaging-as-a-marker-of-inflammation-in-subjects-with-neurological-conditions-65250https://curecurrent.com/trials/using-behavioral-programs-to-treat-sleep-problems-in-individuals-with-alzheimer-s-disease-65251https://curecurrent.com/trials/follow-up-study-of-the-alzheimer-s-disease-anti-inflammatory-prevention-trial-65252https://curecurrent.com/trials/mirtazapine-in-alzheimer-associated-weight-loss-65253https://curecurrent.com/trials/lu-ae58054-added-to-donepezil-for-the-treatment-for-moderate-alzheimer-s-disease-65254https://curecurrent.com/trials/safety-and-tolerability-of-affitope-ad03-65255https://curecurrent.com/trials/evaluation-of-apathy-using-attentional-reaction-test-in-neurodegenerative-diseases-65256https://curecurrent.com/trials/eeg-objectification-in-neuropsychiatry-65257https://curecurrent.com/trials/evaluation-of-the-efficacy-of-varenicline-on-cognition-safety-tolerability-and-pharmacokinetics-in-subjects-with-mild-to-65258https://curecurrent.com/trials/study-to-evaluate-the-safety-pharmacokinetics-and-tolerability-of-bms-708163-65259https://curecurrent.com/trials/rivastigmine-monotherapy-and-combination-therapy-with-memantine-in-patients-with-moderately-severe-alzheimer-s-disease-w-65260https://curecurrent.com/trials/the-dementia-study-in-northern-norway-65261https://curecurrent.com/trials/memantine-communication-study-65262https://curecurrent.com/trials/life-from-vision-in-alzheimer-disease-65263https://curecurrent.com/trials/study-of-social-behavior-and-emotion-in-frontotemporal-dementia-alzheimer-s-disease-and-controls-65264https://curecurrent.com/trials/rivastigmine-in-mild-alzheimer-s-disease-fmri-study-65265https://curecurrent.com/trials/the-occurrence-of-the-apoe4-allele-in-agitated-in-patients-with-late-onset-alzheimer-s-disease-65266https://curecurrent.com/trials/neptune-krill-oil-nko-in-early-stage-alzheimer-s-disease-mnemosyne-65267https://curecurrent.com/trials/functional-magnetic-resonance-imaging-fmri-of-anosognosia-in-amnestic-mild-cognitive-impairment-mci-and-alzheimer-s-dise-65268https://curecurrent.com/trials/memantine-and-antipsychotics-use-65269https://curecurrent.com/trials/psychopathological-risk-factors-associated-with-conversion-from-mild-cognitive-impairment-to-dementia-65270https://curecurrent.com/trials/deep-transcranial-magnetic-stimulation-in-patients-with-alzheimer-s-disease-65271https://curecurrent.com/trials/early-detection-of-mild-cognitive-impairment-in-individual-patients-65272https://curecurrent.com/trials/a-study-of-the-long-term-safety-of-abt-089-for-subjects-with-mild-to-moderate-alzheimer-s-disease-who-participated-in-th-65273https://curecurrent.com/trials/study-to-evaluate-safety-tolerability-and-immunogenicity-of-vaccine-ub-311-in-subjects-with-alzheimer-s-disease-65274https://curecurrent.com/trials/safety-and-efficacy-study-of-abt-089-in-adults-with-mild-to-moderate-alzheimer-s-disease-65275https://curecurrent.com/trials/telephone-call-from-acute-care-physicians-to-long-term-care-physicians-impact-on-transitional-care-of-elderly-patients-65276https://curecurrent.com/trials/multiple-intravenous-dose-study-of-pf-04360365-in-japanese-patients-with-mild-to-moderate-alzheimer-s-disease-65277https://curecurrent.com/trials/rosiglitazone-effects-on-cognition-for-adults-in-later-life-65278https://curecurrent.com/trials/innovative-biomarkers-in-alzheimer-s-disease-and-frontotemporal-dementia-ftd-preventative-and-personalized-65279https://curecurrent.com/trials/a-24-week-multicenter-open-evaluation-of-the-clinical-effectiveness-of-the-once-daily-10-cm-2-rivastigmine-patch-formula-65280https://curecurrent.com/trials/safety-and-efficacy-of-positron-emission-tomography-pet-imaging-with-mni-558-65281https://curecurrent.com/trials/efficacy-and-safety-of-tamibarotene-oam80-for-alzheimer-s-disease-65282https://curecurrent.com/trials/observational-study-to-monitor-long-term-immunogenicity-and-efficacy-of-ub-311-vaccine-in-subjects-with-alzheimer-s-dise-65283https://curecurrent.com/trials/safety-and-efficacy-study-of-magnetic-fields-to-treat-alzheimer-s-disease-65284https://curecurrent.com/trials/study-of-the-role-of-g72-in-amyotrophic-lateral-sclerosis-biomarker-discovery-and-mechanism-investigation-65285https://curecurrent.com/trials/treatment-of-severe-alzheimer-s-disease-evaluation-of-efficacy-and-safety-of-galantamine-hydrobromide-in-a-controlled-st-65286https://curecurrent.com/trials/an-efficacy-and-safety-study-of-inm-176-for-the-treatment-of-patients-with-alzheimer-type-dementia-65287https://curecurrent.com/trials/a-study-of-the-effects-on-sleep-attention-and-gastrointestinal-tolerance-of-galantamine-and-donepezil-in-patients-with-a-65288https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-galantamine-in-patients-with-mild-cognitive-impairment-65289https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-galantamine-in-patients-with-mild-cognitive-impairment-65290https://curecurrent.com/trials/escitalopram-and-depression-in-elderly-alzheimer-s-patients-65291https://curecurrent.com/trials/non-pharmacological-treatment-in-alzheimer-s-disease-and-associated-disorders-65292https://curecurrent.com/trials/study-of-magnetic-fields-to-treat-alzheimer-s-disease-65293https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-risperidone-versus-placebo-in-the-treatment-of-patients-with-hallucinations-a-65294https://curecurrent.com/trials/placebo-controlled-evaluation-of-galantamine-in-the-treatment-of-alzheimer-s-disease-safety-and-efficacy-of-a-controlled-65295https://curecurrent.com/trials/safety-and-tolerability-study-of-extended-release-er-galantamine-in-alzheimer-s-disease-65296https://curecurrent.com/trials/a-randomized-double-blind-flexible-dose-multicenter-study-to-evaluate-the-effectiveness-and-safety-of-galantamine-ir-in-65297https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-two-doses-of-galantamine-versus-placebo-in-the-treatment-of-patients-with-alz-65298https://curecurrent.com/trials/a-cardiac-safety-study-of-galantamine-in-the-treatment-of-alzheimer-s-disease-65299https://curecurrent.com/trials/a-follow-up-study-to-assess-safety-and-tolerability-of-galantamine-treatment-in-individuals-with-mild-cognitive-impairme-65300https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-a-flexible-dose-of-galantamine-versus-placebo-in-the-treatment-of-patients-wi-65301https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-galantamine-versus-placebo-in-the-treatment-of-patients-with-vascular-dementi-65302https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-two-doses-of-galantamine-versus-placebo-in-the-treatment-of-patients-with-alz-65303https://curecurrent.com/trials/an-efficacy-and-safety-study-of-galantamine-for-the-treatment-of-patients-with-alzheimer-s-disease-65304https://curecurrent.com/trials/to-evaluate-effects-of-azd1446-placebo-and-donepezil-in-patients-with-alzheimer-s-disease-65305https://curecurrent.com/trials/exercise-treatment-of-mild-stage-probable-alzheimer-s-disease-65306https://curecurrent.com/trials/use-of-autobiographical-and-interest-assessment-for-a-better-stimulation-of-patients-in-nursing-home-65307https://curecurrent.com/trials/quality-of-life-assessment-in-alzheimer-s-disease-ad-patients-receiving-aricept-tablets-65308https://curecurrent.com/trials/a-phase-1-study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-dimebon-pf-01913539-in-japanese-and-western-65309https://curecurrent.com/trials/mri-to-measure-treatment-with-antibiotics-in-alzheimer-s-disease-65310https://curecurrent.com/trials/computerized-personal-interventions-for-alzheimer-s-patients-65311https://curecurrent.com/trials/effect-of-cognitive-intervention-in-alzheimer-s-disease-ad-on-functional-cortical-networks-in-fmri-65312https://curecurrent.com/trials/study-evaluating-multiple-doses-of-gsi-953-within-the-elderly-population-65313https://curecurrent.com/trials/study-evaluating-the-coadministration-of-begacestat-and-donepezil-65314https://curecurrent.com/trials/earth-413-a-study-of-aricept-in-hispanic-patients-with-mild-to-moderate-alzheimer-s-disease-ad-65315https://curecurrent.com/trials/efficacy-and-safety-of-aricept-in-the-treatment-of-severe-alzheimer-s-disease-65316https://curecurrent.com/trials/non-interventional-study-with-aricept-evess-65317https://curecurrent.com/trials/blood-gene-expression-signature-in-patients-diagnosed-with-probable-alzheimer-s-disease-compared-to-patients-suffering-f-65318https://curecurrent.com/trials/convenience-tolerability-and-safety-of-change-in-the-administration-of-rivastigmine-from-capsules-to-a-transdermal-patch-65319https://curecurrent.com/trials/a-study-of-alzheimer-s-disease-using-magnetoencephalography-meg-and-the-synchronous-neural-interaction-test-65320https://curecurrent.com/trials/alzheimer-s-disease-and-related-disorders-65321https://curecurrent.com/trials/an-escalating-dose-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-lnk-754-in-elderly-volunteers-and-i-65322https://curecurrent.com/trials/study-of-adherence-and-effects-of-balance-exercices-siel-bleu-associatio-65323https://curecurrent.com/trials/treatment-of-apathy-in-alzheimer-s-disease-with-modafinil-65324https://curecurrent.com/trials/aidma-a-psycho-educational-program-designed-to-support-and-train-carers-of-alzheimer-s-disease-ad-patients-65325https://curecurrent.com/trials/pharmacokinetic-comparisons-of-two-donepezil-formulations-65326https://curecurrent.com/trials/alzheimer-s-disease-reminiscence-quality-of-life-65327https://curecurrent.com/trials/effect-of-aricept-on-biomarkers-acetylcholine-sapp-alpha-in-cerebrospinal-fluid-65328https://curecurrent.com/trials/the-effect-of-cognitive-function-as-measured-by-repeated-cognitive-measures-after-12-weeks-treatment-with-donepezil-65329https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-bms-708163-65330https://curecurrent.com/trials/long-term-safety-and-efficacy-of-galantamine-in-alzheimer-s-disease-65331https://curecurrent.com/trials/efficacy-and-safety-of-risperidone-compared-with-placebo-in-the-treatment-of-psychotic-symptoms-in-patients-with-alzheim-65332https://curecurrent.com/trials/trial-of-novel-oral-zinc-cysteine-preparation-in-alzheimer-s-disease-65333https://curecurrent.com/trials/ad01-follow-up-extension-visit-65334https://curecurrent.com/trials/drug-drug-interaction-to-study-the-effect-of-bms-708163-on-pharmacokinetics-pk-of-galantamine-extended-release-er-65335https://curecurrent.com/trials/multiple-dose-japanese-bridging-study-65336https://curecurrent.com/trials/study-of-huperzine-a-sustained-release-tablets-in-patients-with-alzheimer-s-disease-65337https://curecurrent.com/trials/drug-drug-interaction-study-with-rifampin-65338https://curecurrent.com/trials/drug-drug-interaction-study-with-aricept-donepezil-65339https://curecurrent.com/trials/drug-drug-interaction-ddi-w-ketoconazole-or-fluconazole-65340https://curecurrent.com/trials/the-efficacy-of-galantamine-on-the-attention-and-the-frontal-function-of-the-patients-with-dementia-of-alzheimer-type-65341https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-galantamine-in-patients-with-alzheimer-s-disease-65342https://curecurrent.com/trials/cognitive-behavioural-therapy-of-early-dementia-65343https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-risperidone-in-the-treatment-of-behavioral-disturbances-in-patients-with-deme-65344https://curecurrent.com/trials/effect-on-the-electrocardiographic-qt-interval-corrected-for-heart-rate-qtc-in-healthy-subjects-65345https://curecurrent.com/trials/relative-bioavailability-study-of-four-experimental-formulations-for-alzheimer-s-disease-65346https://curecurrent.com/trials/evaluation-of-the-cognision-tm-system-as-an-event-related-potential-erp-collection-system-65347https://curecurrent.com/trials/multiple-dose-study-of-trx0037-65348https://curecurrent.com/trials/study-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-azd0328-in-elderly-healthy-subjects-65349https://curecurrent.com/trials/a-phase-i-single-dose-study-of-pf-04360365-in-japanese-patients-with-mild-to-moderate-alzheimer-s-disease-65350https://curecurrent.com/trials/comparative-bioavailability-in-healthy-elderly-volunteers-65351https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-risperidone-versus-placebo-in-the-treatment-of-behavioral-disturbances-in-pat-65352https://curecurrent.com/trials/memantine-and-changes-of-biological-markers-and-brain-pet-imaging-in-alzheimer-s-disease-65353https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-risperidone-in-the-treatment-of-behavioral-disturbances-in-patients-with-deme-65354https://curecurrent.com/trials/study-of-uptake-break-down-and-elimination-of-an-investigational-drug-in-healthy-volunteers-65355https://curecurrent.com/trials/continuous-arterial-spin-labeling-casl-mri-for-monitoring-and-prediction-of-drug-therapy-in-alzheimers-disease-ad-65356https://curecurrent.com/trials/alzheimer-s-disease-prevention-trial-65357https://curecurrent.com/trials/a-safety-and-tolerability-study-of-abt-126-in-elderly-65358https://curecurrent.com/trials/a-study-of-the-safety-pharmacokinetics-pharmacodynamics-and-immunogenicity-of-anti-abeta-mabt5102a-in-patients-with-alzh-65359https://curecurrent.com/trials/tolerability-and-safety-of-subcutaneous-administration-of-affitope-ad01-in-mild-to-moderate-alzheimer-s-disease-65360https://curecurrent.com/trials/tolerability-and-safety-of-subcutaneous-administration-of-affitope-ad02-in-mild-to-moderate-alzheimer-s-disease-65361https://curecurrent.com/trials/safety-tolerability-immunological-and-clinical-activity-of-a-boost-immunization-with-affitope-ad02-65362https://curecurrent.com/trials/safety-and-efficacy-of-positron-emission-tomography-imaging-with-mni-513-65363https://curecurrent.com/trials/evaluation-of-123i-av94-and-spect-in-subjects-with-alzheimer-disease-in-comparison-to-healthy-subjects-65364https://curecurrent.com/trials/evaluation-of-123i-av151-and-spect-in-subjects-w-ad-in-comparison-to-healthy-subjects-65365https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-memantine-in-moderate-to-severe-alzheimer-s-disease-65366https://curecurrent.com/trials/donepezil-treatment-of-psychotic-symptoms-in-dementia-patients-65367https://curecurrent.com/trials/project-tap-tailored-activities-project-65368https://curecurrent.com/trials/study-evaluating-potential-interaction-between-sam-531-and-gemfibrozil-when-co-administered-65369https://curecurrent.com/trials/effect-of-testosterone-therapy-in-men-with-alzheimer-s-disease-and-low-testosterone-65370https://curecurrent.com/trials/improved-diagnosis-of-alzheimer-s-disease-using-magnetoencephalography-meg-65371https://curecurrent.com/trials/improved-diagnosis-of-alzheimer-s-disease-using-the-synchronous-neural-interaction-test-65372https://curecurrent.com/trials/4-week-safety-and-tolerability-study-in-patients-with-mild-to-moderate-alzheimer-s-disease-65373https://curecurrent.com/trials/evolution-of-memory-related-activity-65374https://curecurrent.com/trials/encapsulated-cell-biodelivery-of-nerve-growth-factor-to-alzheimer-s-disease-patients-65375https://curecurrent.com/trials/effects-of-transcranial-magnetic-stimulation-tms-and-cognitive-training-for-alzheimer-patients-65376https://curecurrent.com/trials/safety-and-feasibility-of-sodium-oxybate-in-mild-alzheimer-s-disease-patients-65377https://curecurrent.com/trials/a-study-of-oral-pf-01913539-in-patients-with-mild-to-moderate-alzheimer-s-disease-65378https://curecurrent.com/trials/solanezumab-safety-study-in-japanese-patients-with-alzheimer-s-disease-65379https://curecurrent.com/trials/long-term-safety-and-tolerability-of-affitope-ad01-65380https://curecurrent.com/trials/long-term-safety-and-tolerability-of-affitope-ad02-65381https://curecurrent.com/trials/exelon-patch-and-combination-with-memantine-comparative-trial-65382https://curecurrent.com/trials/safety-and-efficacy-of-high-dose-rapid-titration-galantamine-in-patients-with-alzheimer-s-disease-65383https://curecurrent.com/trials/do-hmg-coa-reductase-inhibitors-affect-abeta-levels-65384https://curecurrent.com/trials/study-gsi-136-in-healthy-young-and-healthy-elderly-subjects-65385https://curecurrent.com/trials/project-cope-managing-dementia-at-home-65386https://curecurrent.com/trials/lifezig-personalized-reminiscence-video-with-slideshows-and-music-for-individuals-with-alzheimer-s-and-dementia-65387https://curecurrent.com/trials/study-evaluating-the-potential-interaction-between-verapamil-immediate-release-and-sam-531-when-co-administered-65388https://curecurrent.com/trials/a-study-evaluating-the-absorption-of-dimebon-into-the-body-from-a-dimebon-solution-applied-to-the-skin-65389https://curecurrent.com/trials/a-multi-center-randomized-double-blind-parallel-group-study-with-3-groups-receiving-placebo-5-mg-of-e2020-and-10-mg-of-e-65390https://curecurrent.com/trials/disease-modifying-properties-of-lithium-in-the-neurobiology-of-alzheimer-s-disease-65391https://curecurrent.com/trials/a-study-in-healthy-volunteers-to-estimate-the-pharmacokinetics-of-four-modified-release-formulations-of-dimebon-latrepir-65392https://curecurrent.com/trials/a-phase-1-non-randomized-open-label-single-dose-study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-dimebo-65393https://curecurrent.com/trials/amyloid-plaque-and-tangle-imaging-in-alzheimer-s-disease-and-down-syndrome-65394https://curecurrent.com/trials/memory-aid-for-informed-consent-in-alzheimer-s-research-65395https://curecurrent.com/trials/glucose-metabolic-amyloid-and-tau-brain-imaging-in-down-syndrome-and-dementia-65396https://curecurrent.com/trials/implications-of-amyloid-pathology-65397https://curecurrent.com/trials/effect-of-memantine-on-functional-communication-in-patients-with-alzheimer-s-disease-65398https://curecurrent.com/trials/a-dose-ranging-study-to-investigate-the-efficacy-and-safety-of-sb-742457-in-alzheimer-s-disease-65399https://curecurrent.com/trials/predictors-of-cognitive-decline-in-normal-aging-65400https://curecurrent.com/trials/gene-therapy-for-alzheimer-s-disease-clinical-trial-65401https://curecurrent.com/trials/memory-impairment-study-mild-cognitive-impairment-study-65402https://curecurrent.com/trials/antigonadotropin-leuprolide-in-alzheimer-s-disease-drug-investigation-aladdin-vp-104-study-65403https://curecurrent.com/trials/effectiveness-of-a-nutritional-brain-metabolic-enhancer-for-alzheimer-disease-65404https://curecurrent.com/trials/mifepristone-as-adjunctive-therapy-in-alzheimer-s-disease-65405https://curecurrent.com/trials/alzheimer-s-disease-treatment-and-illness-perceptions-survey-tips-ii-65406https://curecurrent.com/trials/estrogen-hormone-protocol-65407https://curecurrent.com/trials/the-safety-and-efficacy-of-an-investigational-drug-in-delaying-the-progression-of-alzheimer-s-disease-65408https://curecurrent.com/trials/a-multicenter-trial-of-rofecoxib-and-naproxen-in-alzheimer-s-disease-nsaid-study-65409https://curecurrent.com/trials/sgs742-in-patients-with-mild-to-moderate-alzheimer-s-disease-ad-65410https://curecurrent.com/trials/aladdin-study-antigonadotropin-leuprolide-in-alzheimer-s-disease-drug-investigation-65411https://curecurrent.com/trials/a-trial-of-sk-pc-b70m-in-mild-to-moderate-alzheimer-s-disease-65412https://curecurrent.com/trials/study-of-single-ascending-and-multiple-doses-of-pf-04447943-in-japanese-subjects-65413https://curecurrent.com/trials/brain-uptake-and-safety-with-probable-alzheimer-s-disease-amnestic-mild-cognitive-impairment-and-healthy-volunteers-65414https://curecurrent.com/trials/curcumin-in-patients-with-mild-to-moderate-alzheimer-s-disease-65415https://curecurrent.com/trials/alzheimer-s-caregiver-communication-study-65416https://curecurrent.com/trials/a-phase-i-study-to-estimate-the-effect-of-ketoconazole-and-omeprazole-on-the-pharmacokinetics-of-dimebon-in-healthy-subj-65417https://curecurrent.com/trials/safety-study-of-a-glycogen-synthase-kinase-3-gsk3-inhibitor-in-patients-with-alzheimer-s-disease-65418https://curecurrent.com/trials/positron-emission-tomography-pet-study-with-18f-azd4694-and-11c-azd2184-candidate-pet-ligands-for-a-amyloid-65419https://curecurrent.com/trials/a-phase-i-single-iv-dose-of-pf-04360365-in-adults-with-mild-to-moderate-alzheimer-s-disease-65420https://curecurrent.com/trials/effects-of-ly2062430-in-subjects-with-mild-to-moderate-alzheimer-s-disease-and-in-healthy-volunteers-65421https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-pk-and-pd-of-sam-531-in-the-subjects-with-mild-to-moderate-alzheimer-s-disease-65422https://curecurrent.com/trials/randomized-safety-tolerability-and-pilot-efficacy-of-an-1792-in-alzheimer-s-disease-65423https://curecurrent.com/trials/pioglitazone-in-alzheimer-disease-65424https://curecurrent.com/trials/a-study-to-determine-the-clinical-safety-tolerability-and-exploratory-efficacy-of-eht-0202-as-adjunctive-therapy-to-acet-65425https://curecurrent.com/trials/passport-to-brain-wellness-in-sedentary-adults-65426https://curecurrent.com/trials/biomarkers-and-early-alzheimer-s-disease-65427https://curecurrent.com/trials/study-evaluating-sra-333-in-mild-to-moderate-alzheimer-s-disease-ad-65428https://curecurrent.com/trials/study-evaluating-how-quickly-and-to-what-extent-the-14-carbon-sam-531-is-absorbed-converted-eliminated-in-male-subjects-65429https://curecurrent.com/trials/magnetic-resonance-imaging-mri-of-brain-iron-in-neurodegenerative-disease-65430https://curecurrent.com/trials/evaluation-of-123i-mni-308-and-spect-as-a-marker-of-beta-amyloid-protein-deposition-in-ad-subjects-compared-to-hc-65431https://curecurrent.com/trials/safety-and-effect-on-memory-of-pym50028-in-mild-alzheimer-s-disease-65432https://curecurrent.com/trials/a-safety-and-tolerability-evaluation-of-two-10-week-dose-regimens-of-orally-administered-pf-04494700-in-alzheimer-s-pati-65433https://curecurrent.com/trials/far-infrared-treatment-for-alzheimer-s-disease-65434https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-sam-531-in-healthy-japanese-males-65435https://curecurrent.com/trials/study-evaluating-paz-417-in-cerebrospinal-fluid-in-subjects-with-alzheimer-s-disease-65436https://curecurrent.com/trials/a-study-of-prx-03140-in-subjects-with-alzheimer-s-disease-receiving-a-stable-dose-of-donepezil-65437https://curecurrent.com/trials/study-of-prx-03140-monotherapy-in-subjects-with-alzheimer-s-disease-65438https://curecurrent.com/trials/study-evaluating-safety-tolerability-and-pharmacokinetics-of-single-and-multiple-dose-of-sam-531-65439https://curecurrent.com/trials/cholesterol-lowering-agent-to-slow-progression-clasp-of-alzheimer-s-disease-study-65440https://curecurrent.com/trials/single-dose-escalation-study-of-pf-04360365-in-subjects-with-mild-to-moderate-alzheimer-s-disease-65441https://curecurrent.com/trials/risk-evaluation-and-education-for-alzheimer-s-disease-65442https://curecurrent.com/trials/risk-evaluation-and-education-for-alzheimer-s-disease-reveal-ii-65443https://curecurrent.com/trials/effect-on-cognitive-performance-and-safety-tolerability-of-ssr180711c-in-mild-alzheimer-s-disease-65444https://curecurrent.com/trials/rasagiline-1-mg-and-2-mg-added-to-aricept-10-mg-daily-in-patients-with-mild-to-moderate-alzheimer-s-disease-ad-65445https://curecurrent.com/trials/a-safety-study-of-ly2811376-single-doses-in-healthy-subjects-65446https://curecurrent.com/trials/study-evaluating-safety-of-gsi-136-in-young-and-elderly-japanese-males-65447https://curecurrent.com/trials/study-evaluating-paz-417-in-healthy-young-elderly-65448https://curecurrent.com/trials/study-evaluating-the-safety-pharmacokinetics-and-pharmacodynamics-of-sam-531-65449https://curecurrent.com/trials/drug-interaction-study-between-azd3480-and-warfarin-65450https://curecurrent.com/trials/drug-interaction-study-between-azd3480-and-aripiprazole-in-healthy-subjects-65451https://curecurrent.com/trials/dimebon-pf-01913539-digoxin-drug-drug-interaction-study-in-healthy-subjects-65452https://curecurrent.com/trials/vital-vitamins-to-slow-alzheimer-s-disease-homocysteine-study-65453https://curecurrent.com/trials/comparative-study-to-test-safety-and-efficacy-of-neurotrophic-and-cholinergic-treatment-of-alzheimer-s-disease-65454https://curecurrent.com/trials/sb-742457-and-donepezil-in-alzheimer-s-disease-65455https://curecurrent.com/trials/pet-changes-in-alzheimer-s-disease-ad-65456https://curecurrent.com/trials/efficacy-study-of-mpc-7869-to-treat-patients-with-alzheimer-s-65457https://curecurrent.com/trials/quetiapine-for-the-treatment-of-insomnia-in-alzheimer-s-disease-65458https://curecurrent.com/trials/bonsai-biomarkers-of-nonsteroidal-anti-inflammatories-65459https://curecurrent.com/trials/anti-oxidant-treatment-of-alzheimer-s-disease-65460https://curecurrent.com/trials/investigation-of-lithium-on-signal-transduction-gene-expression-and-brain-myo-inositol-levels-in-manic-patients-65461https://curecurrent.com/trials/seroquel-agitation-associated-with-dementia-65462https://curecurrent.com/trials/donepezil-and-memantine-in-moderate-to-severe-alzheimer-s-disease-65463https://curecurrent.com/trials/bathing-persons-with-alzheimer-s-disease-at-home-the-bath-study-65464https://curecurrent.com/trials/a-phase-1-study-to-evaluate-the-effect-of-dimebon-on-the-pharmacokinetics-of-dextromethorphan-65465https://curecurrent.com/trials/mirage-multi-institutional-research-in-alzheimer-s-genetic-epidemiology-65466https://curecurrent.com/trials/observational-study-on-costs-and-caregiver-burden-in-alzheimer-s-disease-65467https://curecurrent.com/trials/a-pilot-study-of-inflammatory-markers-in-alzheimer-s-disease-65468https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-and-activity-of-one-dose-of-paz-417-given-to-healthy-japanese-subjects-65469https://curecurrent.com/trials/effects-of-a-complex-cognitive-training-in-mild-cognitive-impairment-and-mild-alzheimer-s-disease-65470https://curecurrent.com/trials/memory-imaging-of-normal-aging-65471https://curecurrent.com/trials/positron-emission-tomography-pet-study-with-11c-azd2995-and-11c-azd2184-candidate-pet-ligands-for-amyloid-65472https://curecurrent.com/trials/alzheimer-s-disease-and-aging-therapeutic-potential-of-estrogen-65473https://curecurrent.com/trials/gene-environment-interactions-in-alzheimer-s-disease-65474https://curecurrent.com/trials/insulin-neurogenetics-and-memory-in-alzheimer-s-disease-65475https://curecurrent.com/trials/electrophysiologic-measures-of-treatment-response-in-alzheimer-disease-65476https://curecurrent.com/trials/specific-interventions-for-agitation-in-alzheimer-s-disease-65477https://curecurrent.com/trials/effects-of-estrogen-on-memory-in-post-menopausal-women-and-patients-with-alzheimer-s-disease-65478https://curecurrent.com/trials/memantine-versus-donepezil-in-early-stages-of-alzheimer-s-disease-65479https://curecurrent.com/trials/a-study-to-assess-the-pharmacokinetics-of-sb-742457-formulated-as-a-capsule-and-a-tablet-in-healthy-elderly-volunteers-65480https://curecurrent.com/trials/long-term-safety-extension-with-sr57667b-in-patients-with-alzheimer-s-disease-65481https://curecurrent.com/trials/activity-of-ave1625-in-mild-to-moderate-alzheimer-s-patients-65482https://curecurrent.com/trials/drug-interaction-study-between-azd3480-and-cytochrome-p450-65483https://curecurrent.com/trials/drug-interaction-study-with-a-potential-alzheimer-s-disease-compound-65484https://curecurrent.com/trials/safety-of-three-formulations-of-ketasyn-administered-for-14-days-in-healthy-elderly-65485https://curecurrent.com/trials/a-study-of-healthy-subjects-to-assess-the-effect-of-ly450139-on-amyloid-beta-peptide-production-rate-and-or-dose-respons-65486https://curecurrent.com/trials/systematic-care-for-informal-caregivers-of-dementia-patients-an-efficient-approach-65487https://curecurrent.com/trials/study-evaluating-potential-pharmacokinetic-pk-interaction-between-lecozotan-and-digoxin-65488https://curecurrent.com/trials/brain-imaging-and-mental-disorders-of-aging-intervention-65489https://curecurrent.com/trials/tracking-technologies-for-the-analysis-of-mobility-in-alzheimer-s-disease-65490https://curecurrent.com/trials/18-month-study-of-the-efficacy-of-xaliproden-sr57746a-in-patients-with-mild-to-moderate-dementia-of-the-alzheimer-s-type-65491https://curecurrent.com/trials/study-of-xaliproden-sr57746a-in-patients-with-mild-to-moderate-dementia-of-the-alzheimer-s-type-65492https://curecurrent.com/trials/european-study-of-hf0220-in-mild-to-moderate-alzheimer-s-disease-patients-65493https://curecurrent.com/trials/global-efficacy-study-of-mpc-7869-to-treat-patients-with-alzheimer-s-65494https://curecurrent.com/trials/open-label-treatment-with-mpc-7869-for-patients-with-alzheimer-s-who-previously-participated-in-an-mpc-7869-protocol-65495https://curecurrent.com/trials/study-evaluating-gsi-953-in-healthy-young-and-alzheimer-s-patients-65496https://curecurrent.com/trials/study-evaluating-safety-tolerability-pharmacokinetics-and-5-ht1a-receptor-occupancy-65497https://curecurrent.com/trials/safety-study-of-cts21166-to-treat-alzheimer-disease-65498https://curecurrent.com/trials/evaluation-of-123i-av83-and-spect-in-patients-with-alzheimer-disease-in-comparison-to-healthy-controls-65499https://curecurrent.com/trials/safety-and-efficacy-of-mem-3454-versus-placebo-in-patients-with-mild-to-moderate-alzheimer-s-disease-65500https://curecurrent.com/trials/safety-and-efficacy-of-mem-1003-versus-placebo-in-patients-with-mild-to-moderate-alzheimer-s-disease-65501https://curecurrent.com/trials/a-pilot-study-of-curcumin-and-ginkgo-for-treating-alzheimer-s-disease-65502https://curecurrent.com/trials/use-of-123i-av39-and-spect-imaging-as-a-marker-of-protein-disposition-in-subjects-with-alzheimer-disease-compared-to-hea-65503https://curecurrent.com/trials/study-evaluating-effects-of-sam-531-on-sleep-electroencephalogram-eeg-and-quantitative-wake-eeg-in-healthy-subjects-65504https://curecurrent.com/trials/the-relationship-between-risperdal-treatment-and-quality-of-life-in-patients-with-alzheimer-s-disease-and-behavioural-an-65505https://curecurrent.com/trials/brain-imaging-in-alzheimer-s-disease-65506https://curecurrent.com/trials/effect-of-lithium-and-divalproex-in-alzheimer-s-disease-65507https://curecurrent.com/trials/preliminary-study-of-fish-oil-and-dementia-65508https://curecurrent.com/trials/genetic-studies-in-alzheimer-s-disease-65509https://curecurrent.com/trials/the-effect-of-short-term-statins-and-nsaids-on-levels-of-beta-amyloid-a-protein-associated-with-alzheimer-s-disease-65510https://curecurrent.com/trials/pet-scan-of-brain-metabolism-in-relation-to-age-and-disease-65511https://curecurrent.com/trials/treatment-of-alzheimer-s-disease-with-cx516-ampalex-65512https://curecurrent.com/trials/nefiracetam-in-the-treatment-of-alzheimer-s-disease-65513https://curecurrent.com/trials/diagnosis-and-natural-history-study-of-patients-with-neurological-conditions-65514https://curecurrent.com/trials/brain-imaging-in-elderly-people-and-individuals-with-alzheimer-s-disease-65515https://curecurrent.com/trials/the-effect-of-acetylcholine-on-memory-and-attention-65516https://curecurrent.com/trials/an-innovative-psychosocial-intervention-for-adult-child-caregivers-of-parents-with-alzheimer-s-disease-65517https://curecurrent.com/trials/huperzine-a-in-alzheimer-s-disease-65518https://curecurrent.com/trials/trx0014-in-patients-with-mild-or-moderate-alzheimer-s-disease-65519https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-sam-315-65520https://curecurrent.com/trials/treatment-with-copper-in-patients-with-mild-alzheimer-s-dementia-65521https://curecurrent.com/trials/prevention-of-cognitive-decline-in-alzheimer-s-disease-by-ingested-interferon-alpha-65522https://curecurrent.com/trials/a-randomized-placebo-controlled-trial-to-examine-the-efficacy-of-oral-donepezil-in-subjects-with-mci-65523https://curecurrent.com/trials/safety-efficacy-pharmacokinetics-and-pharmacodynamics-study-of-bryostatin-1-in-patients-with-alzheimer-s-disease-65524https://curecurrent.com/trials/short-term-effects-of-prx-03140-in-patients-with-mild-alzheimer-s-disease-being-treated-with-aricept-65525https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-and-efficacy-of-pbt2-in-patients-with-early-alzheimer-s-disease-65526https://curecurrent.com/trials/study-of-memantine-in-assessment-of-selected-measures-of-volumetric-magnetic-resonance-imaging-mri-and-cognition-in-mode-65527https://curecurrent.com/trials/the-impact-of-lorazepam-on-cognition-in-apoe-e4-carriers-65528https://curecurrent.com/trials/study-evaluating-the-effect-of-lecozotan-sr-on-the-qtc-interval-65529https://curecurrent.com/trials/safety-and-tolerability-of-rivastigmine-with-add-on-memantine-in-patients-with-probable-alzheimer-s-disease-65530https://curecurrent.com/trials/study-of-the-effects-of-current-drug-treatments-on-levels-of-certain-brain-chemicals-in-alzheimer-s-disease-65531https://curecurrent.com/trials/efficacy-and-safety-of-rivastigmine-in-patients-with-mild-cognitive-impairment-65532https://curecurrent.com/trials/study-evaluating-the-safety-pharmacokinetics-and-pharmacodynamics-of-sam-531-in-healthy-young-and-elderly-subjects-65533https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-sam-531-in-healthy-subjects-65534https://curecurrent.com/trials/european-study-of-3aps-in-mild-to-moderate-alzheimer-s-disease-patients-65535https://curecurrent.com/trials/study-comparing-lecozotan-sr-two-5-mg-tablets-vs-lecozotan-sr-one-10-mg-tablet-in-healthy-subjects-65536https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-pharmacokinetics-pk-and-pharmacodynamics-pd-of-sam-315-in-healthy-adults-65537https://curecurrent.com/trials/single-ascending-dose-study-of-sra-444-in-healthy-subjects-65538https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-sam-315-in-healthy-japanese-males-65539https://curecurrent.com/trials/the-effect-of-anticholinesterase-drugs-on-sleep-in-alzheimer-s-disease-patients-65540https://curecurrent.com/trials/adding-atomoxetine-to-standard-medication-treatment-in-patients-with-alzheimer-s-disease-65541https://curecurrent.com/trials/dopaminergic-enhancement-of-learning-and-memory-in-healthy-adults-and-patients-with-dementia-mild-cognitive-impairment-65542https://curecurrent.com/trials/the-effect-of-melatonin-on-cognitive-function-in-patients-diagnosed-with-mild-cognitive-impairment-65543https://curecurrent.com/trials/pet-study-of-the-nicotinic-receptors-in-human-65544https://curecurrent.com/trials/the-serotonergic-transmitter-system-in-dementia-and-affective-disorders-65545https://curecurrent.com/trials/couples-coping-with-alzheimer-s-disease-65546https://curecurrent.com/trials/aladdin-study-phase-iii-antigonadotropin-leuprolide-in-alzheimer-s-disease-drug-investigation-vp-ad-301-65547https://curecurrent.com/trials/healthy-aging-and-memory-study-65548https://curecurrent.com/trials/diffusion-tensor-weighted-mri-in-alzheimer-s-disease-modifying-treatment-effects-of-galantamine-reminyl-65549https://curecurrent.com/trials/open-label-extension-of-the-phase-iii-study-with-tramiprosate-3aps-in-patients-with-mild-to-moderate-alzheimer-s-disease-65550https://curecurrent.com/trials/effects-of-ly450139-dihydrate-on-subjects-with-mild-to-moderate-alzheimer-s-disease-65551https://curecurrent.com/trials/combining-a-caregiver-intervention-with-aricept-treatment-for-mild-to-moderate-alzheimer-s-disease-65552https://curecurrent.com/trials/gts21-201-for-alzheimer-disease-gts-21-administered-daily-for-28-days-to-participants-with-probable-alzheimer-s-disease-65553https://curecurrent.com/trials/study-evaluating-the-safety-of-lecozotan-sr-in-healthy-young-and-elderly-subjects-65554https://curecurrent.com/trials/evaluating-the-effects-of-music-interventions-on-hospitalised-people-with-dementia-65555https://curecurrent.com/trials/evaluation-of-3aps-in-patients-with-mild-to-moderate-alzheimer-s-disease-65556https://curecurrent.com/trials/effect-of-indomethacin-on-the-progression-of-alzheimer-s-disease-65557https://curecurrent.com/trials/pact-providers-and-alzheimer-s-caregivers-together-65558https://curecurrent.com/trials/lipitor-as-a-treatment-for-alzheimer-s-disease-65559https://curecurrent.com/trials/effect-of-panax-ginseng-on-the-cognitive-performance-in-alzheimer-s-disease-65560https://curecurrent.com/trials/safety-study-of-ppi-1019-in-subjects-with-mild-moderate-alzheimer-s-disease-65561https://curecurrent.com/trials/safety-study-of-ppi-1019-in-patients-with-mild-moderate-alzheimer-s-disease-65562https://curecurrent.com/trials/cognishunt-system-for-alzheimer-s-disease-65563https://curecurrent.com/trials/positron-emission-tomography-of-amyloid-in-alzheimer-s-disease-65564https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-multiple-doses-of-abt-089-in-subjects-with-alzheimer-s-disease-65565https://curecurrent.com/trials/study-of-escitalopram-versus-placebo-in-the-treatment-of-depressive-syndrome-in-alzheimer-s-disease-vascular-dementia-an-65566https://curecurrent.com/trials/care-management-for-patients-with-alzheimer-disease-and-their-family-caregivers-65567https://curecurrent.com/trials/high-intensity-light-therapy-in-alzheimer-s-disease-65568https://curecurrent.com/trials/efficacy-and-safety-of-ly451395-in-patients-with-probable-alzheimer-s-disease-65569https://curecurrent.com/trials/tnf-alpha-inhibition-for-treatment-of-alzheimer-s-disease-65570https://curecurrent.com/trials/tnf-alpha-inhibition-for-treatment-of-alzheimer-s-disease-65571https://curecurrent.com/trials/study-of-the-effect-of-sr57667b-in-patients-with-alzheimer-s-disease-65572https://curecurrent.com/trials/mrs-and-dti-of-white-matter-in-alzheimer-s-disease-65573https://curecurrent.com/trials/calm-ad-65574https://curecurrent.com/trials/metabolic-syndrome-inflammation-and-risk-of-cognitive-decline-65575https://curecurrent.com/trials/influence-of-age-on-hemispheric-lateralization-of-language-a-longitudinal-study-65576https://curecurrent.com/trials/double-blind-study-of-trp01-in-patients-with-alzheimer-s-disease-65577https://curecurrent.com/trials/pain-perception-in-alzheimer-s-disease-65578https://curecurrent.com/trials/coordinating-center-for-enhancing-adrd-caregiving-65579https://curecurrent.com/trials/efficacy-and-safety-study-of-dcb-ad1-in-patients-with-mild-to-moderate-alzheimer-s-disease-65580https://curecurrent.com/trials/multicenter-trial-of-prednisone-in-alzheimer-s-disease-65581https://curecurrent.com/trials/investigation-into-delay-to-diagnosis-of-alzheimer-s-disease-with-exelon-inddex-65582https://curecurrent.com/trials/study-of-melatonin-sleep-problems-in-alzheimer-s-disease-65583https://curecurrent.com/trials/agitation-in-alzheimer-s-disease-65584https://curecurrent.com/trials/evaluation-of-galantamine-in-the-treatment-of-alzheimer-s-disease-65585https://curecurrent.com/trials/single-center-study-of-gustation-in-idiopathic-parkinson-s-disease-and-lewy-body-disease-using-gustatory-evoked-potentia-65586https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-carbidopa-levodopa-extended-release-tablets-in-patients-with-parkinson-s-disease-65587https://curecurrent.com/trials/clinical-trial-evaluating-the-efficacy-and-safety-of-agb101-for-treatment-of-parkinson-s-disease-related-psychosis-65588https://curecurrent.com/trials/tributyrin-for-progressive-supranuclear-palsy-psp-virtual-trial-65589https://curecurrent.com/trials/bilateral-closed-loop-deep-brain-stimulation-for-freezing-of-gait-using-neural-and-kinematic-feedback-65590https://curecurrent.com/trials/the-effect-of-functional-rotational-exercises-on-fall-risk-and-mobility-in-parkinson-s-disease-patients-65591https://curecurrent.com/trials/feasibility-and-safety-of-a-portable-exoskeleton-to-improve-mobility-in-parkinson-s-disease-65592https://curecurrent.com/trials/terazosin-and-metabolic-engagement-in-parkinson-s-disease-65593https://curecurrent.com/trials/short-term-effects-of-a-multimodal-intervention-with-rgm-on-cognition-in-people-with-parkinson-s-disease-65594https://curecurrent.com/trials/deep-brain-stimulation-dbs-retrospective-outcomes-study-65595https://curecurrent.com/trials/substudy-06c-a-study-of-investigational-agents-with-pembrolizumab-mk-3475-and-chemotherapy-in-participants-with-first-li-65596https://curecurrent.com/trials/extended-reality-rehabilitation-in-parkinson-s-disease-65597https://curecurrent.com/trials/a-study-to-evaluate-investigational-agents-with-or-without-pembrolizumab-mk-3475-in-participants-with-advanced-esophagea-65598https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-intravenous-iv-prasinezumab-in-participants-with-early-stage-parkinson-s-65599https://curecurrent.com/trials/long-term-observational-study-on-effectiveness-and-safety-of-lecigon-in-patients-with-advanced-parkinson-s-disease-65600https://curecurrent.com/trials/effect-of-physical-activity-on-the-course-of-parkinson-s-disease-in-patients-with-bilateral-dbs-stn-stimulation-65601https://curecurrent.com/trials/home-based-exercise-program-after-community-balance-training-for-parkinson-s-disease-65602https://curecurrent.com/trials/kinematic-and-neural-dynamics-of-postural-instability-in-parkinson-s-disease-65603https://curecurrent.com/trials/swallowfit-study-in-parkinson-s-disease-65604https://curecurrent.com/trials/a-study-to-evaluate-the-effectiveness-of-two-doses-of-ap-472-as-adjunctive-therapy-to-levodopa-in-parkinson-s-disease-pd-65605https://curecurrent.com/trials/a-clinical-study-of-sacituzumab-tirumotecan-mk-2870-in-combination-with-pembrolizumab-mk-3475-as-first-line-maintenance-65606https://curecurrent.com/trials/a-study-to-compare-sacituzumab-tirumotecan-mk-2870-in-combination-with-pembrolizumab-mk-3475-versus-pembrolizumab-alone-65607https://curecurrent.com/trials/effects-of-mental-imagery-with-self-regulation-on-daily-activities-in-people-with-parkinson-s-disease-65608https://curecurrent.com/trials/closed-loop-programming-evaluation-using-external-responses-for-deep-brain-stimulation-65609https://curecurrent.com/trials/temporal-interference-stimulation-for-motor-and-non-motor-symptoms-in-parkinson-s-disease-65610https://curecurrent.com/trials/a-study-to-investigate-the-pharmacokinetics-and-safety-of-subcutaneous-rilvegostomig-in-adult-participants-with-advanced-65611https://curecurrent.com/trials/pet-scanning-in-parkinson-s-disease-65612https://curecurrent.com/trials/engage-pd-a-physical-activity-coaching-program-via-telehealth-for-people-with-parkinson-s-disease-a-single-cohort-study-65613https://curecurrent.com/trials/spinal-mobility-rigidity-and-kinesiophobia-in-pd-and-tmd-65614https://curecurrent.com/trials/ai-based-differential-diagnosis-and-localization-of-tachycardia-using-ecg-multicenter-registry-ep-ai-assist-65615https://curecurrent.com/trials/agricultural-health-study-follow-up-65616https://curecurrent.com/trials/a-phase-2-study-and-open-label-extension-of-neu-411-in-companion-diagnostic-positive-participants-with-early-parkinson-s-65617https://curecurrent.com/trials/a-study-of-pembrolizumab-mk-3475-in-combination-with-belzutifan-mk-6482-and-lenvatinib-mk-7902-or-pembrolizumab-quavonli-65618https://curecurrent.com/trials/enabling-women-with-parkinson-s-disease-to-identify-and-better-manage-hormonal-triggers-of-parkinsonian-symptoms-65619https://curecurrent.com/trials/a-pilot-study-to-investigate-the-safety-and-clinical-activity-of-avelumab-msb0010718c-in-thymoma-and-thymic-carcinoma-af-65620https://curecurrent.com/trials/long-term-effectiveness-of-levodopa-entacapone-carbidopa-intestinal-gel-in-participants-with-advanced-parkinson-s-diseas-65621https://curecurrent.com/trials/real-world-patient-experiences-with-inbrija-65622https://curecurrent.com/trials/study-to-assess-real-life-effectiveness-of-foslevodopa-foscarbidopa-in-adult-german-participants-at-initial-stages-of-ad-65623https://curecurrent.com/trials/montelukast-in-parkinson-disease-65624https://curecurrent.com/trials/artificial-intelligence-based-parkinson-s-disease-risk-assessment-ai-pra-study-65625https://curecurrent.com/trials/computer-assisted-self-training-to-improve-executive-function-65626https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-aci-7104-056-in-patients-with-early-stages-of-parkinson-s-disease-65627https://curecurrent.com/trials/occupation-based-cognitive-stimulation-with-and-without-motivational-feedback-in-parkinson-s-disease-65628https://curecurrent.com/trials/motor-network-physiology-65629https://curecurrent.com/trials/sustained-release-oral-formulation-for-treatment-of-parkinsons-disease-65630https://curecurrent.com/trials/a-study-of-aav2-gdnf-in-adults-with-moderate-parkinson-s-disease-regenerate-pd-65631https://curecurrent.com/trials/feasibility-of-a-community-based-multimodal-exercise-programme-in-parkinson-s-disease-65632https://curecurrent.com/trials/a-clinical-trial-of-ly3962681-in-healthy-volunteers-and-in-patients-with-parkinson-s-disease-65633https://curecurrent.com/trials/upper-extremity-skills-trunk-control-and-body-awareness-in-parkinson-s-disease-65634https://curecurrent.com/trials/the-role-of-priors-in-hallucinatory-perception-in-parkinson-s-disease-65635https://curecurrent.com/trials/study-of-the-test-retest-reliability-of-the-neuropsychiatric-fluctuations-scale-in-parkinson-39-s-disease-65636https://curecurrent.com/trials/unlocking-movement-potential-enhancing-parkinson-s-disease-treatment-with-robotic-eksoskeleton-65637https://curecurrent.com/trials/the-safety-tolerability-efficacy-of-xs411-cell-injection-for-the-treatment-of-primary-parkinson-s-disease-65638https://curecurrent.com/trials/visual-hallucinations-in-lewy-body-diseases-65639https://curecurrent.com/trials/pembrolizumab-plus-epacadostat-pembrolizumab-monotherapy-and-the-extreme-regimen-in-recurrent-or-metastatic-head-and-nec-65640https://curecurrent.com/trials/the-effects-of-ischemic-conditioning-in-individuals-with-parkinson-s-disease-65641https://curecurrent.com/trials/deep-brain-stimulation-therapy-in-movement-disorders-65642https://curecurrent.com/trials/evaluation-and-treatment-of-neurosurgical-disorders-65643https://curecurrent.com/trials/a-manualized-recreational-therapy-balance-program-for-older-adults-with-parkinson-s-and-movement-disorders-65644https://curecurrent.com/trials/the-parkinson-s-disease-case-control-study-65645https://curecurrent.com/trials/effects-of-excitatory-and-inhibitory-lifus-of-gpi-in-parkinsonian-patients-without-dbs-65646https://curecurrent.com/trials/a-study-to-determine-if-bhv-8000-is-effective-safe-and-tolerable-as-a-treatment-for-adults-living-with-early-parkinson-s-65647https://curecurrent.com/trials/imaging-biomarkers-in-parkinson-s-disease-65648https://curecurrent.com/trials/a-clinical-study-of-intismeran-autogene-v940-and-pembrolizumab-mk-3475-in-people-with-melanoma-v940-012-interpath-012-65649https://curecurrent.com/trials/pulmonary-and-musculoskeletal-impairments-in-parkinson-s-patients-65650https://curecurrent.com/trials/positron-emission-tomography-pet-imaging-in-people-with-gaucher-mutations-65651https://curecurrent.com/trials/velocity-loss-training-and-parkinson-s-disease-65652https://curecurrent.com/trials/long-term-follow-up-ket-pd-65653https://curecurrent.com/trials/bayesian-optimization-of-dbs-for-gait-65654https://curecurrent.com/trials/the-efficacy-of-psilocybin-therapy-for-depression-in-parkinson-s-disease-65655https://curecurrent.com/trials/clinical-laboratory-evaluation-of-chronic-autonomic-failure-65656https://curecurrent.com/trials/gbpdc-gut-brain-in-pd-consortium-master-protocol-65657https://curecurrent.com/trials/a-two-part-single-and-multiple-ascending-dose-trial-of-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-65658https://curecurrent.com/trials/substudy-03a-a-study-of-immune-and-targeted-combination-therapies-in-participants-with-first-line-1l-renal-cell-carcinom-65659https://curecurrent.com/trials/substudy-03b-a-study-of-immune-and-targeted-combination-therapies-in-participants-with-second-line-plus-2l-renal-cell-ca-65660https://curecurrent.com/trials/multicenter-implementation-of-e-monitoring-in-parkinson-s-disease-65661https://curecurrent.com/trials/acute-effects-of-capacitive-resistive-radiofrequency-therapy-in-people-with-parkinson-s-disease-65662https://curecurrent.com/trials/assessment-of-the-safety-immunogenicity-and-pharmacodynamics-of-trb-001-in-patients-with-early-idiopathic-parkinson-s-di-65663https://curecurrent.com/trials/investigating-adaptive-deep-brain-stimulation-in-parkinson-s-disease-management-65664https://curecurrent.com/trials/terazosin-and-metabolic-energetics-in-parkinson-s-disease-65665https://curecurrent.com/trials/efficacy-of-repetitive-transcranial-magnetic-stimulation-for-improving-depressive-symptoms-in-patients-with-parkinson-s-65666https://curecurrent.com/trials/a-12-week-study-of-flexilev-with-the-orafid-device-and-app-in-parkinson-s-patients-65667https://curecurrent.com/trials/sensory-filtering-in-the-human-basal-ganglia-as-a-mechanism-of-parkinson-s-disease-65668https://curecurrent.com/trials/medipd-an-online-mediterranean-diet-program-for-people-living-with-parkinson-s-disease-65669https://curecurrent.com/trials/effects-of-transcutaneous-cervical-vagus-nerve-stimulation-on-non-motor-symptoms-in-parkinson-s-disease-65670https://curecurrent.com/trials/a-study-of-zanidatamab-in-combination-with-chemotherapy-plus-or-minus-tislelizumab-in-patients-with-her2-positive-advanc-65671https://curecurrent.com/trials/istradefylline-for-parkinson-disease-with-cognitive-impairment-65672https://curecurrent.com/trials/effects-of-repetitive-transcranial-magnetic-stimulation-rtms-primed-self-controlled-practice-in-people-with-parkinson-s-65673https://curecurrent.com/trials/remotely-supervised-home-based-transcranial-temporal-interference-stimulation-on-motor-symptoms-in-parkinson-s-disease-65674https://curecurrent.com/trials/effect-of-botulinum-toxin-on-resting-tremor-of-the-refractory-upper-limb-in-parkinsonians-65675https://curecurrent.com/trials/genetic-studies-of-lysosomal-storage-disorders-65676https://curecurrent.com/trials/boxing-based-training-to-improve-balance-and-mobility-in-parkinson-s-disease-65677https://curecurrent.com/trials/integrated-motor-cognitive-training-in-parkinson-s-disease-a-feasibility-study-65678https://curecurrent.com/trials/speech-learning-and-speech-production-in-parkinson-s-disease-65679https://curecurrent.com/trials/asymmetric-targeted-dbs-for-pd-with-pigd-65680https://curecurrent.com/trials/ancillary-study-no-3-ns-park-omics-65681https://curecurrent.com/trials/balance-performance-and-quality-of-life-in-parkinson-s-disease-65682https://curecurrent.com/trials/neurophysiology-biomarkers-of-cognitive-impairment-associated-with-deep-brain-stimulation-65683https://curecurrent.com/trials/dual-task-balance-and-gait-training-combined-with-cognitive-training-in-parkinson-s-patients-65684https://curecurrent.com/trials/blood-flow-restriction-aerobic-exercise-for-balance-and-anxiety-in-parkinson-s-disease-65685https://curecurrent.com/trials/study-to-test-effects-and-safety-of-ro7568282-in-early-parkinson-s-disease-65686https://curecurrent.com/trials/a-study-of-buntanetap-in-participants-with-pd-65687https://curecurrent.com/trials/first-in-human-study-of-aln-snca-in-adult-participants-with-early-parkinson-s-disease-pd-65688https://curecurrent.com/trials/this-protocol-is-a-sub-study-under-the-ppmi-program-it-is-a-longitudinal-single-center-study-to-assess-the-performance-o-65689https://curecurrent.com/trials/low-dose-carbon-monoxide-hbi-002-trial-to-evaluate-safety-tolerability-pk-and-biomarkers-in-parkinson-s-disease-65690https://curecurrent.com/trials/spinal-cord-stimulation-for-freezing-of-gait-in-parkinson-s-disease-65691https://curecurrent.com/trials/mri-guided-temporal-interference-stimulation-for-parkinson-s-disease-65692https://curecurrent.com/trials/new-approaches-in-mri-at-3t-dedicated-to-targeting-subthalamic-nucleus-on-parkinsonian-patients-65693https://curecurrent.com/trials/passive-versus-active-music-therapy-parkinson-s-disease-65694https://curecurrent.com/trials/analysis-of-cutaneous-phosphorylated-alpha-synuclein-to-identify-patients-at-risk-of-progressing-from-essential-tremor-t-65695https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-in-combination-with-adjuvant-chemotherapy-with-or-without-radiotherapy-in-participants-wi-65696https://curecurrent.com/trials/neurodegenerative-diseases-registry-65697https://curecurrent.com/trials/clinical-and-physiological-studies-of-tremor-syndromes-65698https://curecurrent.com/trials/physiological-investigations-of-movement-disorders-65699https://curecurrent.com/trials/natural-history-protocol-for-movement-disorders-65700https://curecurrent.com/trials/stimulating-specific-brain-areas-vop-vim-with-electricity-to-improve-movement-and-muscle-control-65701https://curecurrent.com/trials/atr-1072-in-participants-with-prkag2-syndrome-65702https://curecurrent.com/trials/vismemopd-protocol-an-observational-pilot-study-on-spatial-and-topographical-memory-in-patients-with-parkinson-s-disease-65703https://curecurrent.com/trials/neuroplasticity-in-parkinson-s-disease-65704https://curecurrent.com/trials/resveratrol-in-parkinson-s-disease-reset-65705https://curecurrent.com/trials/phase-1-2a-clinical-trial-of-pr001-ly3884961-in-patients-with-parkinson-s-disease-with-at-least-one-gba1-mutation-propel-65706https://curecurrent.com/trials/hereditary-parkinson-s-disease-natural-history-protocol-65707https://curecurrent.com/trials/does-hippotherapy-have-an-effect-on-mobility-gait-balance-and-perceived-health-related-quality-of-life-in-persons-with-p-65708https://curecurrent.com/trials/a-trial-of-ono-2808-in-participants-with-the-parkinsonian-subtype-of-multiple-system-atrophy-msa-p-65709https://curecurrent.com/trials/visuomotor-control-in-parkinson-disease-65710https://curecurrent.com/trials/self-controlled-practice-on-motor-learning-and-motivation-in-parkinson-s-disease-65711https://curecurrent.com/trials/db-rct-for-specialized-phototherapy-in-parkinson-s-disease-65712https://curecurrent.com/trials/benefits-of-different-exercise-types-to-enhance-walking-for-pd-65713https://curecurrent.com/trials/stereotactic-radiosurgery-for-essential-tremor-and-parkinsonian-tremor-65714https://curecurrent.com/trials/treatment-of-cognitive-and-sensorimotor-deficits-in-parkinson-s-disease-with-high-definition-transcranial-direct-current-65715https://curecurrent.com/trials/identifying-the-neural-signature-of-exercise-to-advance-treatment-of-pd-cognitive-declines-65716https://curecurrent.com/trials/registry-of-deep-brain-stimulation-with-the-vercise-system-vercise-dbs-registry-65717https://curecurrent.com/trials/the-effect-of-eye-exercises-in-parkinson-s-disease-65718https://curecurrent.com/trials/the-effect-of-beechband-on-parkinson-s-symptoms-65719https://curecurrent.com/trials/a-phase-i-study-in-healthy-volunteers-and-parkinson-s-disease-pd-patients-65720https://curecurrent.com/trials/effects-of-microelectrode-based-brain-stimulation-in-humans-65721https://curecurrent.com/trials/autologous-ipsc-derived-dopamine-neuron-transplantation-for-parkinson-s-disease-65722https://curecurrent.com/trials/digital-patient-engagement-in-technology-supported-neurorehabilitation-65723https://curecurrent.com/trials/coordinated-reset-deep-brain-stimulation-for-parkinson-s-disease-65724https://curecurrent.com/trials/simplified-scalable-24-hour-adaptive-dbs-in-parkinson-s-disease-65725https://curecurrent.com/trials/automated-daytime-adaptive-deep-brain-stimulation-parameter-optimization-in-patients-implanted-with-percept-neurostimula-65726https://curecurrent.com/trials/neurofeedback-using-implanted-deep-brain-stimulation-electrodes-65727https://curecurrent.com/trials/prove-of-concept-study-to-evaluate-the-efficacy-safety-and-tolerability-of-iberogast-in-the-treatment-of-bowel-troubles-65728https://curecurrent.com/trials/theta-deep-brain-stimulation-for-cognitive-enhancement-in-parkinson-s-disease-65729https://curecurrent.com/trials/earlier-diagnosis-and-better-treatment-mission-related-to-the-cohort-programme-65730https://curecurrent.com/trials/comparison-of-benzhexol-and-procyclidine-for-tremor-in-tremor-predominant-parkinson-s-disease-65731https://curecurrent.com/trials/effectiveness-of-a-home-based-exercise-program-supported-by-self-management-education-in-people-with-parkinson-disease-65732https://curecurrent.com/trials/analysis-of-the-enteric-nervous-system-using-colonic-biopsies-65733https://curecurrent.com/trials/efficacy-and-safety-of-crisugabalin-on-nociplastic-pain-in-patients-with-parkinson-s-disease-relief-pd-a-multicentre-dou-65734https://curecurrent.com/trials/turkish-validity-and-reliability-of-the-parkinson-s-disease-neuropsychometric-dementia-assessment-questionnaire-in-indiv-65735https://curecurrent.com/trials/dual-frequency-stimulation-in-parkinson-s-disease-65736https://curecurrent.com/trials/wearable-biofeedback-for-swallowing-disorders-rehabilitation-in-stroke-and-parkinson-disease-65737https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-pk-safety-and-tolerability-of-vim0423-in-adults-with-parkinson-s-disease-tremor-insuffi-65738https://curecurrent.com/trials/radiofrequency-rf-ablation-prospective-outcomes-study-for-central-nervous-system-rapid-for-cns-65739https://curecurrent.com/trials/synthetic-vasomotion-for-glymphatic-enhancement-65740https://curecurrent.com/trials/cognitive-rehabilitation-with-virtual-reality-in-parkinson-disease-65741https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-of-prasinezumab-ro7046015-prx002-in-participants-with-early-parkinson-s-disease-65742https://curecurrent.com/trials/safety-tolerability-and-symptomatic-efficacy-of-the-rock-inhibitor-fasudil-in-patients-with-parkinson-s-disease-65743https://curecurrent.com/trials/a-study-to-assess-change-in-sleep-disturbances-of-adult-participants-with-advanced-parkinson-s-disease-receiving-subcuta-65744https://curecurrent.com/trials/dtx-algorithms-for-personalized-parkinson-s-disease-treatment-and-medication-plan-optimization-65745https://curecurrent.com/trials/digital-app-for-speech-health-monitoring-65746https://curecurrent.com/trials/an-unblinded-single-arm-pilot-observational-study-to-test-the-safety-tolerability-immunogenicity-and-the-biological-effe-65747https://curecurrent.com/trials/a-late-phase-ii-clinical-trial-of-kdt-3594-in-patients-with-parkinson-s-disease-65748https://curecurrent.com/trials/idiopathic-parkinson-s-disease-interest-of-an-early-group-based-cognitive-rehabilitation-program-lifecog-pd-65749https://curecurrent.com/trials/adaptive-dbs-algorithm-for-personalized-therapy-in-parkinson-s-disease-adapt-pd-china-study-65750https://curecurrent.com/trials/disease-modifying-efficacy-of-sitagliptin-therapy-in-early-stage-parkinson-s-disease-65751https://curecurrent.com/trials/gamification-and-physical-activity-in-pd-65752https://curecurrent.com/trials/a-study-of-adjuvant-pembrolizumab-vibostolimab-mk-7684a-versus-pembrolizumab-for-resected-high-risk-melanoma-in-particip-65753https://curecurrent.com/trials/closed-loop-therapeutic-refinement-using-local-field-potentials-in-parkinson-s-disease-65754https://curecurrent.com/trials/stn-ttis-modulates-parkinson-motor-symptoms-with-and-without-medications-65755https://curecurrent.com/trials/effect-of-motor-imagery-added-to-rehabilitation-on-balance-and-kinesiophobia-in-patients-with-parkinson-s-disease-65756https://curecurrent.com/trials/development-of-digital-diagnostic-devices-for-parkinson-s-disease-65757https://curecurrent.com/trials/metformin-in-parkinson-s-disease-safety-and-efficacy-65758https://curecurrent.com/trials/home-based-self-management-and-cognitive-training-changes-lives-hobscotch-parkinson-s-disease-hobscotch-parkinson-s-65759https://curecurrent.com/trials/parkinson-s-improvement-activated-by-hula-understanding-pahu-part-2-65760https://curecurrent.com/trials/a-comparative-performance-study-between-high-and-standard-resolution-positron-emission-tomography-camera-using-18f-av-13-65761https://curecurrent.com/trials/driving-performance-in-parkinson-s-disease-and-multiple-sclerosis-using-a-driving-simulator-65762https://curecurrent.com/trials/monoamine-oxidase-b-pet-ct-in-various-mao-b-related-disease-65763https://curecurrent.com/trials/parkinson-s-foundation-pd-generation-genetic-registry-65764https://curecurrent.com/trials/investigating-basal-ganglia-cortical-physiology-during-sleep-and-its-modulation-by-adaptive-deep-brain-stimulation-in-pa-65765https://curecurrent.com/trials/a-trial-investigating-lu-af28996-in-adults-with-parkinson-s-disease-who-have-motor-fluctuations-65766https://curecurrent.com/trials/early-detection-of-selected-neuropathologies-in-motor-vehicle-drivers-65767https://curecurrent.com/trials/parkinson-progression-marker-initiative-online-ppmi-online-65768https://curecurrent.com/trials/alpha-synuclein-pet-ct-in-various-syn-related-disease-65769https://curecurrent.com/trials/impact-of-subthalamic-nucleus-deep-brain-stimulation-on-cognitive-and-psychiatric-symptoms-in-parkinson-s-disease-65770https://curecurrent.com/trials/testing-the-feasibility-of-an-online-guided-writing-intervention-designed-for-informal-caregivers-of-people-with-parkins-65771https://curecurrent.com/trials/a-us-study-that-observes-how-parkinson-s-disease-changes-over-time-in-patients-who-still-have-movement-symptoms-despite-65772https://curecurrent.com/trials/evaluation-of-the-effects-of-levodopa-benserazide-drug-combination-on-periodontal-status-in-patients-with-parkinson-s-di-65773https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-intravenous-prasinezumab-in-participants-with-early-parkinson-s-disease-65774https://curecurrent.com/trials/effect-on-parkinson-s-disease-after-therapeutic-induction-of-craniosacral-integrated-therapy-65775https://curecurrent.com/trials/split-belt-treadmill-training-for-freezing-of-gait-in-parkinson-s-disease-65776https://curecurrent.com/trials/neurofeedback-rehabilitation-with-fes-and-vr-for-pd-65777https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-efficacy-study-of-radotinib-in-parkinson-s-disease-65778https://curecurrent.com/trials/predicting-cognition-after-dbs-for-parkinson-s-disease-2-65779https://curecurrent.com/trials/safety-and-efficacy-of-lenvatinib-e7080-mk-7902-with-pembrolizumab-mk-3475-in-combination-with-transarterial-chemoemboli-65780https://curecurrent.com/trials/cortical-electrophysiology-of-response-inhibition-in-parkinson-s-disease-65781https://curecurrent.com/trials/safety-and-tolerability-of-irl757-in-participants-with-parkinson-s-disease-and-apathy-65782https://curecurrent.com/trials/connectomic-guided-dbs-for-parkinson-s-disease-65783https://curecurrent.com/trials/destiny-endometrial01-a-phase-iii-study-of-trastuzumab-deruxtecan-plus-rilvegostomig-or-pembrolizumab-as-first-line-trea-65784https://curecurrent.com/trials/vg081821ac-tablets-for-early-to-mid-stage-parkinson-s-disease-65785https://curecurrent.com/trials/psilocybin-therapy-for-depression-and-anxiety-in-parkinson-s-disease-65786https://curecurrent.com/trials/substudy-06d-combination-therapies-in-second-line-2l-gastroesophageal-adenocarcinoma-mk-3475-06d-keymaker-u06-65787https://curecurrent.com/trials/physiology-imaging-and-modeling-of-essential-tremor-65788https://curecurrent.com/trials/exercise-brain-energetics-in-pd-65789https://curecurrent.com/trials/anodic-stimulation-in-parkinson-s-disease-65790https://curecurrent.com/trials/to-evaluate-the-dose-response-effects-of-a-defined-volume-of-physical-exercise-on-the-change-of-peripheral-biomarkers-cl-65791https://curecurrent.com/trials/phase-iia-randomized-placebo-controlled-trial-mesenchymal-stem-cells-as-a-disease-modifying-therapy-for-idiopathic-parki-65792https://curecurrent.com/trials/pechakucha-versus-powerpoint-for-parkinson-s-disease-education-in-nurses-65793https://curecurrent.com/trials/the-gba-multimodal-study-in-parkinson-s-disease-65794https://curecurrent.com/trials/sensor-based-optimization-of-therapy-for-parkinson-s-disease-patients-with-motor-fluctuations-65795https://curecurrent.com/trials/long-term-follow-up-of-glutamic-acid-decarboxylase-gad-gene-transfer-in-parkinson-s-disease-65796https://curecurrent.com/trials/a-study-of-coformulated-favezelimab-pembrolizumab-mk-4280a-versus-physician-s-choice-chemotherapy-in-pd-l-1-refractory-r-65797https://curecurrent.com/trials/deep-brain-stimulation-surgery-for-movement-disorders-65798https://curecurrent.com/trials/a-study-to-evaluate-satety-tolerability-biodistribution-radiation-dosimetry-and-pharmacokinetics-of-sst001-in-healthy-vo-65799https://curecurrent.com/trials/real-world-study-of-foslevodopa-foscarbidopa-to-assess-quality-of-life-outcomes-in-adult-participants-earlier-within-adv-65800https://curecurrent.com/trials/cerebellar-transcranial-alternating-current-stimulation-tacs-to-modulate-parkinson-s-disease-tremor-65801https://curecurrent.com/trials/optimizing-adaptive-dbs-for-parkinson-s-disease-65802https://curecurrent.com/trials/substudy-02a-safety-and-efficacy-of-pembrolizumab-in-combination-with-investigational-agents-in-participants-with-progra-65803https://curecurrent.com/trials/effects-of-a-multicomponent-protocol-with-emphasis-on-muscle-power-training-on-bradykinesia-in-individuals-with-parkinso-65804https://curecurrent.com/trials/a-study-to-evaluate-feasibility-safety-and-clinical-responses-of-implanting-autologous-peripheral-nerve-tissue-into-the-65805https://curecurrent.com/trials/cont-of-a-study-to-evaluate-implanting-peripheral-nerve-grafts-into-subjects-with-parkinson-s-disease-pd-during-dbs-65806https://curecurrent.com/trials/feasibility-and-safety-of-autologous-unconditioned-peripheral-nerve-tissue-delivery-to-the-substantia-nigra-guide-65807https://curecurrent.com/trials/autologous-sural-nerve-grafting-to-the-substantia-nigra-in-patients-with-synuclienopathies-65808https://curecurrent.com/trials/constipation-and-changes-in-the-gut-flora-in-parkinson-s-disease-65809https://curecurrent.com/trials/wearable-for-assessing-tremor-and-continuous-health-in-parkinson-s-disease-and-essential-tremor-65810https://curecurrent.com/trials/a-model-of-hospital-territory-management-coordinated-by-a-case-manager-to-improve-the-care-of-patients-with-parkinsonism-65811https://curecurrent.com/trials/novel-shoe-device-nushu-to-measure-gait-analysis-in-parkinson-s-patients-65812https://curecurrent.com/trials/anesthesia-and-postoperative-delirium-in-parkinson-dbs-65813https://curecurrent.com/trials/deep-brain-stimulation-neural-recordings-of-varied-stimulation-during-sleep-in-parkinson-s-disease-65814https://curecurrent.com/trials/a-study-of-mk-6837-as-a-monotherapy-and-combination-therapy-in-participants-with-advanced-metastatic-solid-tumors-mk-683-65815https://curecurrent.com/trials/gastrointestinal-dopamine-decarboxylase-and-levodopa-pharmacokinetics-65816https://curecurrent.com/trials/exploring-the-olfactory-mucosa-blood-and-urine-for-the-identification-of-early-biomarkers-of-parkinson-s-disease-atypica-65817https://curecurrent.com/trials/accelerated-rtms-for-apathy-in-parkinson-s-disease-65818https://curecurrent.com/trials/rtms-as-an-intervention-for-levodopa-induced-dyskinesia-65819https://curecurrent.com/trials/segmental-laser-acupuncture-for-constipation-and-sleep-in-patients-with-parkinson-s-disease-65820https://curecurrent.com/trials/a-comprehensive-multimodal-characterization-of-prodromal-pd-in-subjects-with-rbd-65821https://curecurrent.com/trials/aav2-haadc-for-parkinson-s-disease-pdcs-01-65822https://curecurrent.com/trials/slow-speed-slowing-parkinson-s-early-through-exercise-dosage-65823https://curecurrent.com/trials/substudy-02c-safety-and-efficacy-of-pembrolizumab-in-combination-with-investigational-agents-or-pembrolizumab-alone-in-p-65824https://curecurrent.com/trials/aav2-gdnf-for-advanced-parkinson-s-disease-65825https://curecurrent.com/trials/slow-speed-nl-slowing-parkinson-s-early-through-exercise-dosage-netherlands-65826https://curecurrent.com/trials/effects-of-tai-chi-therapy-versus-qi-gong-in-stage-i-parkinson-s-patients-65827https://curecurrent.com/trials/pembrolizumab-placebo-plus-trastuzumab-plus-chemotherapy-in-human-epidermal-growth-factor-receptor-2-positive-her2-advan-65828https://curecurrent.com/trials/comparative-bioavailability-study-of-carbidopa-levodopa-extended-release-tablets-under-fasting-and-fed-conditions-65829https://curecurrent.com/trials/physiological-brain-atlas-development-65830https://curecurrent.com/trials/characterization-and-validation-of-the-short-physical-performance-battery-in-individuals-diagnosed-with-parkinson-s-dise-65831https://curecurrent.com/trials/lithium-for-parkinson-s-an-extension-trial-65832https://curecurrent.com/trials/the-effect-of-the-reaction-training-in-parkinson-s-disease-65833https://curecurrent.com/trials/tdcs-of-the-primary-motor-cortex-to-improve-implicit-motor-sequence-learning-in-parkinson-s-disease-65834https://curecurrent.com/trials/unilateral-and-staged-bilateral-pallidothalamic-tractotomy-using-exablate-mrgfus-in-advanced-parkinson-s-disease-65835https://curecurrent.com/trials/a-digital-therapeutic-platform-for-swallowing-and-drooling-problems-in-parkinson-s-65836https://curecurrent.com/trials/an-exploratory-study-of-the-potential-for-rational-immune-system-manipulation-to-prevent-emergence-of-synucleinopathy-ma-65837https://curecurrent.com/trials/correlation-of-stn-dbs-induced-visuospatial-changes-and-freezing-of-gait-65838https://curecurrent.com/trials/a-novel-digital-music-based-autonomous-personalized-walking-intervention-to-improve-gait-and-walking-automaticity-in-par-65839https://curecurrent.com/trials/cnf-dbs-for-levodopa-resistant-fog-65840https://curecurrent.com/trials/combined-genome-and-rna-sequencing-for-genetic-diagnosis-of-parkinsonism-65841https://curecurrent.com/trials/efficacy-and-safety-of-pembrolizumab-mk-3475-plus-lenvatinib-e7080-mk-7902-plus-chemotherapy-in-participants-with-metast-65842https://curecurrent.com/trials/stn-ttis-with-different-intervention-intervals-versus-standard-medical-treatment-for-parkinson-s-disease-65843https://curecurrent.com/trials/genetics-and-aerobic-exercise-to-slow-parkinson-s-disease-trial-65844https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-exidavnemab-in-patients-with-parkinson-s-disease-and-patients-with-multiple-65845https://curecurrent.com/trials/cross-system-effects-of-acute-intermittent-hypercapnia-based-interventions-in-pd-65846https://curecurrent.com/trials/induction-pd-1-inhibitor-and-chemotherapy-followed-by-chemoradiotherapy-in-unresectable-or-inoperable-hpv-negative-la-hn-65847https://curecurrent.com/trials/a-study-of-pembrolizumab-mk-3475-in-combination-with-belzutifan-mk-6482-and-lenvatinib-mk-7902-or-pembrolizumab-quavonli-65848https://curecurrent.com/trials/french-parkinson-s-disease-cohort-ns-park-65849https://curecurrent.com/trials/telehealth-in-lewy-body-dementia-65850https://curecurrent.com/trials/adaptive-neurostimulation-to-restore-sleep-in-parkinson-s-disease-65851https://curecurrent.com/trials/personalized-real-time-dbs-and-pd-mechanisms-65852https://curecurrent.com/trials/exploring-the-efficacy-of-the-effortful-swallow-maneuver-for-improving-swallowing-in-people-with-pd-65853https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-efficacy-and-pk-of-fhl-301-in-parkinson-s-disease-patients-65854https://curecurrent.com/trials/pimavanserin-vs-quetiapine-for-treatment-of-parkinson-s-psychosis-65855https://curecurrent.com/trials/the-validity-and-reliability-of-an-improved-paper-grasping-test-for-parkinson-s-disease-65856https://curecurrent.com/trials/research-into-the-expression-of-the-csga-gene-and-how-it-changes-in-patients-with-parkinson-s-disease-65857https://curecurrent.com/trials/study-of-chemotherapy-with-pembrolizumab-mk-3475-followed-by-maintenance-with-olaparib-mk-7339-for-the-first-line-treatm-65858https://curecurrent.com/trials/home-based-exercise-programs-for-fall-prevention-in-parkinson-disease-65859https://curecurrent.com/trials/bracing-for-walking-in-parkinson-s-disease-65860https://curecurrent.com/trials/neuromodulation-for-patients-with-parkinson-s-disease-65861https://curecurrent.com/trials/transplantation-of-human-ips-cell-derived-dopaminergic-progenitors-ct1-dap001-for-parkinson-s-disease-phase-i-ii-65862https://curecurrent.com/trials/a-phase-2-study-to-assess-the-effects-of-sul-238-on-high-energy-phosphates-with-p-mrs-in-patients-with-early-untreated-p-65863https://curecurrent.com/trials/enhancement-of-quality-of-work-and-life-65864https://curecurrent.com/trials/a-pilot-study-of-in-lab-dynamic-standing-in-parkinson-s-disease-65865https://curecurrent.com/trials/advance-care-planning-and-care-coordination-for-people-with-parkinson-s-disease-65866https://curecurrent.com/trials/exablate-transcranial-mrgfus-of-the-subthalamic-nucleus-for-treatment-of-parkinson-s-disease-65867https://curecurrent.com/trials/safinamide-vs-placebo-for-pain-in-patients-with-parkinson-s-disease-and-motor-fluctuations-65868https://curecurrent.com/trials/daily-amino-acid-supplementation-for-people-with-parkinson-s-disease-65869https://curecurrent.com/trials/lifus-for-neurological-disorders-65870https://curecurrent.com/trials/a-targeted-amino-acid-supplement-for-people-with-parkinson-s-disease-65871https://curecurrent.com/trials/studies-of-frontal-lobe-brain-functioning-in-schizophrenia-65872https://curecurrent.com/trials/the-university-of-alabama-at-birmingham-uab-neuroinflammation-in-parkinson-s-disease-tspo-positron-emission-tomography-p-65873https://curecurrent.com/trials/phase-clinical-trial-to-evaluate-the-efficacy-and-safety-of-tj0113-capsules-in-patients-with-early-onset-parkinson-s-dis-65874https://curecurrent.com/trials/brain-dopamine-biomarker-65875https://curecurrent.com/trials/young-onset-parkinson-s-disease-subtypes-and-pathogenic-mechanisms-65876https://curecurrent.com/trials/longitudinal-tspo-pet-imaging-with-18f-dpa-714-in-ppmi-ppmi-dpa-714-pet-imaging-65877https://curecurrent.com/trials/nad-supplementation-in-parkinson-s-disease-65878https://curecurrent.com/trials/a-study-of-ne3107-in-early-parkinson-s-65879https://curecurrent.com/trials/sl-start-sublingual-apomorphine-schemes-of-titration-in-real-world-treatment-65880https://curecurrent.com/trials/different-frequency-temporal-interference-stimulation-on-bilateral-subthalamic-nucleus-for-parkinson-s-disease-65881https://curecurrent.com/trials/the-efficacy-and-safety-of-temporal-interference-stimulation-on-motor-symptoms-of-parkinson-s-disease-65882https://curecurrent.com/trials/neo-reeduc-mixed-reality-for-motor-rehabilitation-a-prospective-multicenter-controlled-randomized-open-study-65883https://curecurrent.com/trials/augmented-reality-treadmill-training-in-patients-with-parkinson-s-disease-65884https://curecurrent.com/trials/imaging-biomarkers-of-fog-response-to-dbs-65885https://curecurrent.com/trials/a-trial-of-lu-af28996-in-participants-with-parkinson-s-disease-pd-65886https://curecurrent.com/trials/effects-of-transcranial-pulse-stimulation-in-parkinson-s-disease-65887https://curecurrent.com/trials/evaluation-of-tau-pathology-in-sporadic-and-lrrk2-parkinson-s-disease-65888https://curecurrent.com/trials/a-study-of-mk-1484-as-monotherapy-and-in-combination-with-pembrolizumab-mk-3475-in-advanced-or-metastatic-solid-tumors-m-65889https://curecurrent.com/trials/5-ht-rbd-rem-sleep-behavior-disorder-65890https://curecurrent.com/trials/compassionate-use-for-bia-28-6156-in-patients-with-parkinson-s-disease-pd-who-have-a-pathogenic-variant-in-the-gba1-gene-65891https://curecurrent.com/trials/objective-longitudinal-assessment-of-postural-stability-and-gait-of-stroke-parkinson-s-disease-and-multiple-sclerosis-us-65892https://curecurrent.com/trials/study-of-mk-0472-in-participants-with-advanced-metastatic-solid-tumors-mk-0472-001-65893https://curecurrent.com/trials/psilocybin-therapy-for-depression-in-parkinson-s-disease-65894https://curecurrent.com/trials/blood-pressure-effects-on-cognition-and-brain-blood-flow-in-pd-65895https://curecurrent.com/trials/effect-of-midodrine-vs-abdominal-compression-on-cardiovascular-risk-markers-in-autonomic-failure-patients-65896https://curecurrent.com/trials/autologous-bone-marrow-aspirate-iv-and-bone-marrow-concentrate-intranasal-for-parkinson-s-disease-and-parkinson-plus-syn-65897https://curecurrent.com/trials/effects-of-transcutaneous-vagus-nerve-stimulation-in-parkinson-s-disease-65898https://curecurrent.com/trials/user-friendliness-of-a-portable-driving-simulator-65899https://curecurrent.com/trials/characterization-of-the-serotonin-2a-receptor-selective-pet-tracer-18f-mh-mz-in-patients-with-neurodegenerative-diseases-65900https://curecurrent.com/trials/gut-microbiota-and-tryptophan-metabolites-in-parkinson-s-disease-65901https://curecurrent.com/trials/the-influence-of-vibrotactile-stimulation-on-self-selected-walking-speed-in-people-with-parkinson-s-disease-65902https://curecurrent.com/trials/decoding-the-neural-mechanisms-underlying-postural-instability-and-gait-dysfunction-in-parkinson-s-disease-65903https://curecurrent.com/trials/action-observation-and-motor-imagery-therapy-in-parkinson-s-disease-65904https://curecurrent.com/trials/quality-of-life-index-q-index-65905https://curecurrent.com/trials/towards-the-use-of-instrumented-tests-for-screening-the-risk-of-falling-in-patients-with-chronic-illness-65906https://curecurrent.com/trials/phase-i-study-to-evaluate-kp405-in-healthy-and-parkinson-s-disease-patients-65907https://curecurrent.com/trials/investigation-of-exercise-capacity-muscle-oxygenation-and-physical-activity-level-in-parkinson-s-patients-65908https://curecurrent.com/trials/comparative-study-of-tis-efficacy-across-different-targets-65909https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-safety-and-tolerability-of-bbm-p002-in-the-treatment-of-parkinson-s-disease-65910https://curecurrent.com/trials/perceptual-decision-making-under-conditions-of-visual-uncertainty-65911https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-bemdaneprocel-in-adults-who-have-parkinson-s-disease-65912https://curecurrent.com/trials/rehabilitation-with-dual-task-exercises-to-improve-balance-in-patients-with-parkinson-s-disease-65913https://curecurrent.com/trials/test-retest-trial-with-11c-modag-005-in-pd-or-msa-and-amhc-pilot-phase-65914https://curecurrent.com/trials/effects-of-transcranial-focused-ultrasound-stimulation-tfus-on-neurological-and-cognitive-outcomes-in-parkinson-s-diseas-65915https://curecurrent.com/trials/automated-imaging-differentiation-of-parkinsonism-65916https://curecurrent.com/trials/study-of-pembrolizumab-given-prior-to-surgery-and-in-combination-with-radiotherapy-given-post-surgery-for-advanced-head-65917https://curecurrent.com/trials/music-therapy-in-parkinson-s-disease-65918https://curecurrent.com/trials/endurance-exercise-virtual-reality-for-optimizing-cortical-excitability-and-neuroplasticity-in-pd-65919https://curecurrent.com/trials/adapted-physical-activity-and-tango-based-therapy-for-parkinson-s-disease-a-pilot-study-65920https://curecurrent.com/trials/study-of-transanal-irrigation-vs-standard-care-for-constipation-gut-microbiota-and-motor-disorders-in-parkinson-s-diseas-65921https://curecurrent.com/trials/parkinson-s-research-in-metagenomic-early-stage-biomarkers-65922https://curecurrent.com/trials/deep-brain-stimulation-in-parkinson-s-disease-motor-and-functional-outcomes-65923https://curecurrent.com/trials/a-study-of-ab-1005-gene-therapy-in-japanese-adults-with-moderate-parkinson-s-disease-j-regenerate-pd-65924https://curecurrent.com/trials/phase-i-ii-clinical-trial-of-ux-da003-injection-for-the-treatment-of-patients-with-parkinson-s-disease-65925https://curecurrent.com/trials/parkinson-disease-and-dbs-cognitive-effects-in-gba-mutation-carriers-65926https://curecurrent.com/trials/moderate-versus-high-volume-light-moderate-intensity-exercise-for-people-with-moderate-parkinson-s-disease-65927https://curecurrent.com/trials/parkinson-ballroom-fitness-the-impact-of-personalized-dance-on-motor-and-nonmotor-symptoms-in-people-with-parkinson-s-65928https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-a-combination-of-favezelimab-mk-4280-and-pembrolizumab-mk-3475-in-participa-65929https://curecurrent.com/trials/transcranial-magnetic-stimulation-for-freezing-of-gait-in-parkinson-s-disease-65930https://curecurrent.com/trials/efficacy-of-lsvt-loud-therapy-on-voice-speech-and-quality-of-life-in-parkinson-s-disease-65931https://curecurrent.com/trials/40-hz-flickering-for-insomnia-in-parkinson-s-disease-65932https://curecurrent.com/trials/remote-ischemic-conditioning-for-sleep-disturbances-and-other-non-motor-symptoms-in-parkinson-s-disease-65933https://curecurrent.com/trials/neural-mechanisms-of-aerobic-exercise-benefits-in-pd-with-dbs-65934https://curecurrent.com/trials/predicting-parkinson-s-disease-before-it-strikes-a-brain-imaging-study-in-at-risk-individual-65935https://curecurrent.com/trials/effectiveness-of-resistance-exercises-added-to-aerobic-and-balance-exercises-in-parkinson-s-disease-65936https://curecurrent.com/trials/open-label-study-to-evaluate-brain-synuclein-deposition-using-pet-and-18f-mk-0947-in-parkinson-s-disease-65937https://curecurrent.com/trials/prescriptive-infusion-algorithm-pia-65938https://curecurrent.com/trials/cholinergic-mechanisms-of-attentional-motor-integration-and-gait-dysfunction-in-parkinson-disease-udall-65939https://curecurrent.com/trials/ppmi-clinical-establishing-a-deeply-phenotyped-pd-cohort-65940https://curecurrent.com/trials/telemedicine-intervention-in-patients-with-chronic-pain-in-pd-65941https://curecurrent.com/trials/a-study-to-assess-safety-and-efficacy-of-surgical-implant-of-rndp-001-in-patients-with-idiopathic-parkinson-s-disease-65942https://curecurrent.com/trials/pre-gene-therapy-study-in-parkinson-s-disease-and-multiple-system-atrophy-65943https://curecurrent.com/trials/evaluation-of-advanced-imaging-and-visualization-for-clinical-deep-brain-stimulation-65944https://curecurrent.com/trials/study-on-the-incidence-of-malignant-neoplasms-in-patients-with-parkinson-s-disease-and-heterozygous-mutation-of-the-gba-65945https://curecurrent.com/trials/lenrispodun-as-adjunctive-therapy-in-the-treatment-of-patients-with-motor-fluctuations-due-to-parkinson-s-disease-65946https://curecurrent.com/trials/investigating-the-increased-risk-of-falls-in-individuals-with-parkinson-s-disease-treated-with-deep-brain-stimulation-65947https://curecurrent.com/trials/effect-of-hand-rehabilitation-on-cognitive-function-in-patients-with-pd-65948https://curecurrent.com/trials/effects-of-wild-blueberry-ingestion-on-motor-performance-of-people-with-parkinson-s-disease-65949https://curecurrent.com/trials/effects-of-whole-body-vibration-versus-proprioceptive-neuromuscular-facilitation-pattern-with-rhythmic-based-training-on-65950https://curecurrent.com/trials/zr001-chemogenetics-gene-therapy-study-in-patients-with-parkinson-s-disease-65951https://curecurrent.com/trials/intranasal-insulin-and-glutathione-as-an-add-on-therapy-in-parkinson-s-disease-65952https://curecurrent.com/trials/tms-in-anxiety-parkinson-s-disease-65953https://curecurrent.com/trials/impact-of-exercise-on-muscle-metabolism-and-function-for-persons-with-parkinsons-65954https://curecurrent.com/trials/behavioral-and-or-mirabegron-to-treat-urinary-symptoms-in-parkinson-disease-65955https://curecurrent.com/trials/novel-dbs-stimulation-patterns-for-treatment-of-parkinson-s-disease-65956https://curecurrent.com/trials/perioperative-pembrolizumab-mk-3475-plus-neoadjuvant-chemotherapy-versus-perioperative-placebo-plus-neoadjuvant-chemothe-65957https://curecurrent.com/trials/turkish-validity-and-reliability-of-the-heat-sensitivity-scale-for-individuals-with-parkinson-s-disease-65958https://curecurrent.com/trials/to-assess-the-efficacy-and-safety-of-ceftriaxone-in-patients-with-mild-to-moderate-parkinson-s-disease-dementia-65959https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-versus-placebo-in-participants-with-esophageal-carcinoma-who-are-receiving-chemotherapy-a-65960https://curecurrent.com/trials/accelerated-temporal-interference-stimulation-on-bilateral-subthalamic-nucleus-for-parkinson-s-disease-and-secondary-par-65961https://curecurrent.com/trials/the-impact-of-deep-brain-stimulation-on-speech-and-swallow-function-in-parkinson-disease-65962https://curecurrent.com/trials/neuro-immune-interactome-in-parkinson-s-disease-65963https://curecurrent.com/trials/subthalamic-nucleus-stn-targeted-transcranial-temporal-interference-stimulation-tis-for-parkinson-s-disease-efficacy-and-65964https://curecurrent.com/trials/modification-of-threat-interpretation-bias-to-reduce-anxiety-in-neurodegenerative-movement-disorders-aim-3-65965https://curecurrent.com/trials/a-study-of-dimdazenil-in-patients-with-parkinson-s-disease-and-insomnia-65966https://curecurrent.com/trials/deep-brain-stimulation-for-patients-with-parkinson-s-disease-65967https://curecurrent.com/trials/a-multifactorial-exercise-program-to-reduce-falls-in-people-with-parkinson-disease-65968https://curecurrent.com/trials/futibatinib-tas-120-in-patients-with-advanced-biliary-tract-cancer-65969https://curecurrent.com/trials/a-behavioral-digital-intervention-for-parkinson-s-disease-65970https://curecurrent.com/trials/perioperative-enfortumab-vedotin-ev-plus-pembrolizumab-mk-3475-versus-neoadjuvant-chemotherapy-for-cisplatin-eligible-mu-65971https://curecurrent.com/trials/association-of-vagus-nerve-stimulation-and-treadmill-training-for-gait-rehabilitation-in-de-novo-parkinson-s-disease-65972https://curecurrent.com/trials/determinants-of-physical-frailty-in-parkinson-s-disease-a-multi-factorial-analysis-65973https://curecurrent.com/trials/a-study-of-mk-6598-as-monotherapy-and-in-combination-with-pembrolizumab-mk-3475-in-advanced-solid-tumors-mk-6598-001-65974https://curecurrent.com/trials/turkish-cognitive-self-efficacy-questionnaire-in-parkinson-s-disease-65975https://curecurrent.com/trials/neurophysiology-of-locomotor-adaptation-and-freezing-of-gait-in-parkinson-s-disease-65976https://curecurrent.com/trials/self-compassion-and-self-efficacy-in-parkinson-s-disease-associations-with-symptoms-function-and-quality-of-life-65977https://curecurrent.com/trials/parkinson-s-improvement-activated-by-hula-understanding-65978https://curecurrent.com/trials/directional-psa-versus-stn-dbs-for-td-pd-65979https://curecurrent.com/trials/multicontext-approach-for-cognitive-function-in-parkinson-disease-65980https://curecurrent.com/trials/mental-imagery-on-upper-extremity-skills-65981https://curecurrent.com/trials/whole-body-vibration-in-parkinson-disease-65982https://curecurrent.com/trials/superior-parietal-itbs-for-pd-mci-65983https://curecurrent.com/trials/sensory-specific-peripheral-stimulation-for-tremor-management-65984https://curecurrent.com/trials/primary-parkinsonian-pain-clinical-association-and-phenotype-65985https://curecurrent.com/trials/virtual-cycling-environments-for-persons-with-parkinson-disease-65986https://curecurrent.com/trials/temporal-interference-noninvasive-deep-brain-stimulation-for-idiopathic-parkinson-s-disease-and-parkinsonian-syndromes-e-65987https://curecurrent.com/trials/intestinal-levodopa-entacapone-therapy-lecigon-to-counteract-dopaminergic-desensitization-and-neuropsychiatric-complicat-65988https://curecurrent.com/trials/virtual-reality-on-balance-of-parkinson-s-disease-65989https://curecurrent.com/trials/a-study-of-adjuvant-intismeran-autogene-v940-and-pembrolizumab-in-renal-cell-carcinoma-v940-004-65990https://curecurrent.com/trials/real-life-on-parkinson-s-italy-reonpark-it-65991https://curecurrent.com/trials/safety-tolerability-and-exploratory-efficacy-of-ec5026-in-parkinson-s-disease-step-study-65992https://curecurrent.com/trials/pedunculopontine-nucleus-transcranial-ultrasound-stimulation-as-a-treatment-of-freezing-of-gait-in-parkinson-s-disease-65993https://curecurrent.com/trials/lrrk2-leucine-rich-repeat-kinase-2-parkinson-s-disease-fingerprint-65994https://curecurrent.com/trials/multidisciplinary-lifestyle-interventions-for-neurological-disorders-during-the-silent-phase-65995https://curecurrent.com/trials/a-study-to-assess-change-in-disease-symptoms-in-adult-participants-with-advanced-parkinson-disease-using-subcutaneous-fo-65996https://curecurrent.com/trials/study-in-parkinson-disease-of-exercise-65997https://curecurrent.com/trials/in-vivo-noradrenergic-system-and-aging-65998https://curecurrent.com/trials/which-tools-better-predict-fall-risk-in-parkinson-s-disease-a-comparative-study-of-objective-self-reported-and-functiona-65999https://curecurrent.com/trials/non-invasive-vns-for-parkinson-s-gait-66000https://curecurrent.com/trials/a-clinical-study-evaluating-efficacy-of-pirepemat-on-falls-frequency-in-patients-with-parkinson-s-disease-pd-66001